' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Publikationen

Gewähltes Keyword: chemotherapy


Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate.
Apostolidis, L; Nientiedt, C; Winkler, EC; Berger, AK; Kratochwil, C; Kaiser, A; Becker, AS; Jäger, D; Hohenfellner, M; Hüttenbrink, C; Pahernik, S; Distler, FA; Grüllich, C;
Oncotarget. 2019; 10(1): 17-29.
Originalarbeiten (Zeitschrift)
Prediction of Distant Recurrence Using EndoPredict Among Women with ER
Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, CF; Hlauschek, D; Brown, K; Bernhisel, R; Kronenwett, R; Lancaster, JM; Fitzal, F; Gnant, M;
Clin Cancer Res. 2019; 25(13):3865-3872
Originalarbeiten (Zeitschrift)
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder, SP; Peer, A; Weismann, C; Meissnitzer, M; Rinnerthaler, G; Webhofer, J; Westphal, T; Riedmann, M; Meissnitzer, T; Egger, H; Klaassen Federspiel, F; Reitsamer, R; Hauser-Kronberger, C; Stering, K; Hergan, K; Mlineritsch, B; Greil, R;
Breast Cancer Res. 2019; 21(1):19
Originalarbeiten (Zeitschrift)
Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
Gasser, E; Braunwarth, E; Riedmann, M; Cardini, B; Fadinger, N; Presl, J; Klieser, E; Ellmerer, P; Dupré, A; Imai, K; Malik, H; Baba, H; Ulmer, H; Schneeberger, S; Öfner, D; Dinnewitzer, A; Stättner, S; Primavesi, F;
PLoS One. 2019; 14(5):e0217411
Originalarbeiten (Zeitschrift)
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Huemer, F; Melchardt, T; Jansko, B; Wahida, A; Jilg, S; Jost, PJ; Klieser, E; Katja, S; Magnes, T; Pleyer, L; Greil-Ressler, S; Rass, C; Greil, R; Egle, A;
Eur J Haematol. 2019; 102(5):437-441
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: further results from the prospective PANTHER study with focus on obese patients.
Matikas, A; Foukakis, T; Moebus, V; Greil, R; Bengtsson, NO; Steger, GG; Untch, M; Johansson, H; Hellström, M; Malmström, P; Gnant, M; Loibl, S; Bergh, J;
Ann Oncol. 2019; 30(1): 109-114.
Originalarbeiten (Zeitschrift)
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.
Neuhauser, M; Roetzer, T; Oberndorfer, S; Kitzwoegerer, M; Payer, F; Unterluggauer, JJ; Haybaeck, J; Stockhammer, G; Iglseder, S; Moser, P; Thome, C; Stultschnig, M; Wuertz, F; Brandner-Kokalj, T; Weis, S; Bandke, D; Pichler, J; Hutterer, M; Krenosz, KJ; Boehm, A; Mayrbaeurl, B; Hager-Seifert, A; Kaufmann, H; Dumser, M; Reiner-Concin, A; Hoenigschnabl, S; Kleindienst, W; Hoffermann, M; Dieckmann, K; Kiesel, B; Widhalm, G; Marosi, C; Jaeger, U; Hainfellner, A; Hackl, M; Hainfellner, JA; Preusser, M; Woehrer, A
Acta Oncol. 2019; 1-10
Originalarbeiten (Zeitschrift)
Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study group.
Primavesi, F; Klieser, E; Cardini, B; Marsoner, K; Fröschl, U; Thalhammer, S; Fischer, I; Hauer, A; Urbas, R; Kiesslich, T; Neureiter, D; Zitt, M; Klug, R; Wundsam, H; Sellner, F; Karner, J; Függer, R; Cakar-Beck, F; Kornprat, P; Öfner, D; Stättner, S;
Eur J Surg Oncol. 2019; 45(2):198-206
Originalarbeiten (Zeitschrift)
Progressive Oncological Surgery Is Associated with Increased Curative Resection Rates and Improved Survival in Metastatic Colorectal Cancer.
Primavesi, F; Stättner, S; Jäger, T; Göbel, G; Presl, J; Tomanová, K; Buchner, S; Maglione, M; Resch, T; Hutter, J; Öfner, D; Dinnewitzer, A;
Cancers (Basel). 2019; 11(2):
Originalarbeiten (Zeitschrift)
Pancreatic cancer in young adults: changes, challenges, and solutions.
Primavesi, F; Stättner, S; Schlick, K; Kiesslich, T; Mayr, C; Klieser, E; Urbas, R; Neureiter, D;
Onco Targets Ther. 2019; 12:3387-3400
Übersichtsarbeiten
Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis.
Solass, W; Sempoux, C; Carr, N; Bibeau, F; Neureiter, D; Jäger, T; Di Caterino, T; Brunel, C; Klieser, E; Fristrup, C; Mortensen, MB; Detlefsen, S;
Histopathology. 2019; 74(7):1014-1024
Originalarbeiten (Zeitschrift)
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.
Bachmayer, S; Fastner, G; Vaszi, A; Iglseder, W; Kopp, P; Holzinger, J; Dinnewitzer, A; Rinnerthaler, G; Gampenrieder, SP; Emmanuel, K; Greil, R; Sedlmayer, F; Zehentmayr, F;
Strahlenther Onkol. 2018; 194(7): 627-637.
Originalarbeiten (Zeitschrift)
PET-guided treatment in patients with advanced-stage Hodgkins lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
Borchmann, P; Goergen, H; Kobe, C; Lohri, A; Greil, R; Eichenauer, DA; Zijlstra, JM; Markova, J; Meissner, J; Feuring-Buske, M; Hüttmann, A; Dierlamm, J; Soekler, M; Beck, HJ; Willenbacher, W; Ludwig, WD; Pabst, T; Topp, MS; Hitz, F; Bentz, M; Keller, UB; Kühnhardt, D; Ostermann, H; Schmitz, N; Hertenstein, B; Aulitzky, W; Maschmeyer, G; Vieler, T; Eich, H; Baues, C; Stein, H; Fuchs, M; Kuhnert, G; Diehl, V; Dietlein, M; Engert, A;
Lancet. 2018; 390(10114): 2790-2802.
Originalarbeiten (Zeitschrift)
Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study.
Brueckl, WM; Achenbach, HJ; Ficker, JH; Schuette, W;
BMC Cancer. 2018; 18(1): 333
Originalarbeiten (Zeitschrift)
Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).
Falantes, J; Pleyer, L; Thépot, S; Almeida, AM; Maurillo, L; Martínez-Robles, V; Stauder, R; Itzykson, R; Pinto, R; Venditti, A; Bargay, J; Burgstaller, S; Martínez, MP; Seegers, V; Cortesão, E; Foncillas, MÁ; Gardin, C; Montesinos, P; Musto, P; Fenaux, P; Greil, R; Sanz, MA; Ramos, F;
Leuk Lymphoma. 2018; 59(5):1113-1120
Originalarbeiten (Zeitschrift)
Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.
Greil, R; Pleyer, L; Jansko, B; Feierabend, C; Rettenbacher, L; Stiefel, O; Rass, C; Morre, P; Neureiter, D; Greil-Ressler, S;
Oncotarget. 2018; 9(29): 20928-20940.
Originalarbeiten (Zeitschrift)
A proposal for a tailored approach to diverting ostomy for colorectal anastomosis.
Manzenreiter, L; Spaun, G; Weitzendorfer, M; Luketina, R; Antoniou, SA; Wundsam, H; Koch, OO; Emmanuel, K;
Minerva Chir. 2018; 73(1):29-35
Originalarbeiten (Zeitschrift)
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Piringer, G; Fridrik, M; Fridrik, A; Leiherer, A; Zabernigg, A; Greil, R; Eisterer, W; Tschmelitsch, J; Lang, A; Frantal, S; Burgstaller, S; Gnant, M; Thaler, J;
Support Care Cancer. 2018; 26(4):1345-1352
Originalarbeiten (Zeitschrift)
Oncotype DX® in breast cancer patients: clinical experience, outcome and follow-up-a case-control study.
Rath, MG; Uhlmann, L; Fiedler, M; Heil, J; Golatta, M; Dinkic, C; Hennigs, A; Schott, S; Ernst, V; Koch, T; Sohn, C; Brucker, C; Rom, J;
Arch Gynecol Obstet. 2018; 297(2):443-447
Originalarbeiten (Zeitschrift)
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Sasse, S; Goergen, H; Plütschow, A; Böll, B; Eichenauer, DA; Fuchs, M; Behringer, K; Zijlstra, JM; Greil, R; Markova, J; Topp, MS; Meissner, J; Neubauer, A; Baues, C; Engert, A; Borchmann, P; von Tresckow, B;
J Clin Oncol. 2018; 36(25): 2603-2611.
Originalarbeiten (Zeitschrift)
Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 2: clinical features, diagnosis and differential diagnostics.
Schlee, S; Bollheimer, LC; Bertsch, T; Sieber, CC; Härle, P;
Z Gerontol Geriatr. 2018; 51(5):579-584
Übersichtsarbeiten
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
Schlick, K; Magnes, T; Ratzinger, L; Jaud, B; Weiss, L; Melchardt, T; Greil, R; Egle, A;
PLoS One. 2018; 13(11): e0206688
Originalarbeiten (Zeitschrift)
Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.
Schommers, P; Gillor, D; Hentrich, M; Wyen, C; Wolf, T; Oette, M; Zoufaly, A; Wasmuth, JC; Bogner, JR; Müller, M; Esser, S; Schleicher, A; Jensen, B; Stoehr, A; Behrens, G; Schultze, A; Siehl, J; Thoden, J; Taylor, N; Hoffmann, C;
Haematologica. 2018; 103(5): 857-864.
Originalarbeiten (Zeitschrift)
Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
Schwartz, C; Romagna, A; Machegger, L; Weiss, L; Huemer, F; Fastner, G; Kleindienst, W; Serge, W; Greil, R; Winkler, PA;
World Neurosurg. 2018; 120:442-447
Fallberichte
Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Vetterlein, MW; Gild, P; Kluth, LA; Seisen, T; Gierth, M; Fritsche, HM; Burger, M; Protzel, C; Hakenberg, OW; von Landenberg, N; Roghmann, F; Noldus, J; Nuhn, P; Pycha, A; Rink, M; Chun, FK; May, M; Fisch, M; Aziz, A;
BJU Int. 2018; 121(1): 101-110.
Originalarbeiten (Zeitschrift)
Cure in metastatic breast cancer.
Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Greil, R;
Memo. 2018; 11(3):172-179
Übersichtsarbeiten
Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma.
Wirries, A; Jabari, S; Jansen, EP; Roth, S; Figueroa-Juárez, E; Wissniowski, TT; Neureiter, D; Klieser, E; Lechler, P; Ruchholtz, S; Bartsch, DK; Boese, CK; Di Fazio, P;
Oncotarget. 2018; 9(68):32997-33010
Originalarbeiten (Zeitschrift)
Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease.
Zschäbitz, S; Distler, FA; Krieger, B; Wuchter, P; Schäfer-Eckart, K; Jenzer, M; Hohenfellner, M; Dreger, P; Haag, GM; Jäger, D; Pahernik, S; Grüllich, C;
Oncotarget. 2018; 9(32): 22537-22545.
Originalarbeiten (Zeitschrift)
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
Almeida, AM; Prebet, T; Itzykson, R; Ramos, F; Al-Ali, H; Shammo, J; Pinto, R; Maurillo, L; Wetzel, J; Musto, P; Van De Loosdrecht, AA; Costa, MJ; Esteves, S; Burgstaller, S; Stauder, R; Autzinger, EM; Lang, A; Krippl, P; Geissler, D; Falantes, JF; Pedro, C; Bargay, J; Deben, G; Garrido, A; Bonanad, S; Diez-Campelo, M; Thepot, S; Ades, L; Sperr, WR; Valent, P; Fenaux, P; Sekeres, MA; Greil, R; Pleyer, L
INT J MOL SCI. 2017; 18(4): 837
Originalarbeiten (Zeitschrift)
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkins lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
Borchmann, P; Haverkamp, H; Lohri, A; Mey, U; Kreissl, S; Greil, R; Markova, J; Feuring-Buske, M; Meissner, J; Dührsen, U; Ostermann, H; Keller, U; Maschmeyer, G; Kuhnert, G; Dietlein, M; Kobe, C; Eich, H; Baues, C; Stein, H; Fuchs, M; Diehl, V; Engert, A;
Lancet Oncol. 2017; 18(4): 454-463.
Originalarbeiten (Zeitschrift)
Advanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: first-line treatment with afatinib and other EGFR TKIs.
Brückl, W; Tufman, A; Huber, RM;
Expert Rev Anticancer Ther. 2017; 17(2): 143-155.
Originalarbeiten (Zeitschrift)
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Curigliano, G; Burstein, HJ; P Winer, E; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, HJ; Thürlimann, B; André, F; Baselga, J; Bergh, J; Bonnefoi, H; Y Brucker, S; Cardoso, F; Carey, L; Ciruelos, E; Cuzick, J; Denkert, C; Di Leo, A; Ejlertsen, B; Francis, P; Galimberti, V; Garber, J; Gulluoglu, B; Goodwin, P; Harbeck, N; Hayes, DF; Huang, CS; Huober, J; Hussein, K; Jassem, J; Jiang, Z; Karlsson, P; Morrow, M; Orecchia, R; Osborne, KC; Pagani, O; Partridge, AH; Pritchard, K; Ro, J; Rutgers, EJT; Sedlmayer, F; Semiglazov, V; Shao, Z; Smith, I; Toi, M; Tutt, A; Viale, G; Watanabe, T; Whelan, TJ; Xu, B;
Ann Oncol. 2017; 28(8): 1700-1712.
Originalarbeiten (Zeitschrift)
Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany.
Dall, P; Koch, T; Göhler, T; Selbach, J; Ammon, A; Eggert, J; Gazawi, N; Rezek, D; Wischnik, A; Hielscher, C; Keitel, S; Cirrincione, U; Hinke, A; Feisel-Schwickardi, G;
Oncologist. 2017; 22(2): 131-138.
Originalarbeiten (Zeitschrift)
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J;
Anticancer Res. 2017; 37(5):2683-2691
Originalarbeiten (Zeitschrift)
Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer.
Gampenrieder, SP; Hufnagl, C; Brechelmacher, S; Huemer, F; Hackl, H; Rinnerthaler, G; Romeder, F; Monzo Fuentes, C; Morre, P; Hauser-Kronberger, C; Mlineritsch, B; Greil, R;
Pharmacogenomics J. 2017; 17(4):344-350
Originalarbeiten (Zeitschrift)
Antiangiogenic therapy in breast cancer.
Gampenrieder, SP; Westphal, T; Greil, R;
Memo. 2017; 10(4):194-201
Übersichtsarbeiten
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
Hack, CC; Fasching, PA; Fehm, T; de Waal, J; Rezai, M; Baier, B; Baake, G; Kolberg, HC; Guggenberger, M; Warm, M; Harbeck, N; Wuerstlein, R; Deuker, JU; Dall, P; Richter, B; Wachsmann, G; Brucker, C; Siebers, JW; Fersis, N; Kuhn, T; Wolf, C; Vollert, HW; Breitbach, GP; Janni, W; Landthaler, R; Kohls, A; Rezek, D; Noesslet, T; Fischer, G; Henschen, S; Praetz, T; Heyl, V; Kühn, T; Krauss, T; Thomssen, C; Hohn, A; Tesch, H; Mundhenke, C; Hein, A; Rauh, C; Bayer, CM; Jacob, A; Schmidt, K; Belleville, E; Hadji, P; Brucker, SY; Wallwiener, D; Kümmel, S; Beckmann, MW; Paepke, D;
Integr Cancer Ther. 2017; 16(2): 165-175.
Originalarbeiten (Zeitschrift)
Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations.
Heidrich, K; Thiede, C; Schafer-Eckart, K; Schmitz, N; Aulitzky, WE; Kramer, A; Rosler, W; Hanel, M; Einsele, H; Baldus, CD; Trappe, RU; Stolzel, F; Middeke, JM; Rollig, C; Taube, F; Kramer, M; Serve, H; Berdel, WE; Ehninger, G; Bornhauser, M; Schetelig, J
ANN ONCOL. 2017; 28(11): 2793-2798.
Originalarbeiten (Zeitschrift)
[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study].
Heigener, DF; Hoeffken, G; Wuerflein, D; Feurer, M; Rittmeyer, A; Huber, RM; Pietsch, M; Ring, A; Deppermann, KM
DEUT MED WOCHENSCHR. 2017; 142(4): e21-e27.
Originalarbeiten (Zeitschrift)
Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.
Magnes, T; Egle, A; Greil, R; Melchardt, T;
MEMO-MAG EUR MED ONC. 2017; 10(4): 220-223.
Übersichtsarbeiten
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
Magnes, T; Melchardt, T; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Gampenrieder, S; Moser, G; Gaggl, A; Greil, R; Egle, A;
PLoS One. 2017; 12(7):e0180995
Originalarbeiten (Zeitschrift)
The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians.
Martini, T; Gilfrich, C; Mayr, R; Burger, M; Pycha, A; Aziz, A; Gierth, M; Stief, CG; Muller, SC; Wagenlehner, F; Roigas, J; Hakenberg, OW; Roghmann, F; Nuhn, P; Wirth, M; Novotny, V; Hadaschik, B; Grimm, MO; Schramek, P; Haferkamp, A; Colleselli, D; Kloss, B; Herrmann, E; Fisch, M; May, M; Bolenz, C
CLIN GENITOURIN CANC. 2017; 15(3): 356-362.
Originalarbeiten (Zeitschrift)
Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
May, M; Fritsche, HM; Vetterlein, MW; Bastian, PJ; Gierth, M; Nuhn, P; Aziz, A; Fisch, M; Stief, CG; Hohenfellner, M; Wirth, MP; Novotny, V; Hakenberg, OW; Noldus, J; Gilfrich, C; Bolenz, C; Burger, M; Brookman-May, SD;
World J Urol. 2017; 35(2): 24-250.
Originalarbeiten (Zeitschrift)
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.
May, M; Protzel, C; Vetterlein, MW; Gierth, M; Noldus, J; Karl, A; Grimm, T; Wullich, B; Grimm, MO; Nuhn, P; Bastian, PJ; Roigas, J; Hadaschik, B; Gilfrich, C; Burger, M; Fisch, M; Brookman-May, S; Aziz, A; Hakenberg, OW;
Int Urol Nephrol. 2017; 49(2): 247-254.
Originalarbeiten (Zeitschrift)
Microcystic adnexal carcinoma (MAC)-like squamous cell carcinoma as a differential diagnosis to Bell´s palsy: review of guidelines for refractory facial nerve palsy.
Mueller, SK; Iro, H; Lell, M; Seifert, F; Bohr, C; Scherl, C; Agaimy, A; Traxdorf, M;
J Otolaryngol Head Neck Surg. 2017; 46(1): 1
Fallberichte
Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer.
Niedersüss-Beke, D; Puntus, T; Kunit, T; Grünberger, B; Lamche, M; Loidl, W; Böhm, R; Kraischits, N; Kudlacek, S; Schramek, P; Meran, JG;
Oncology. 2017; 93(1): 36-42.
Originalarbeiten (Zeitschrift)
Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancy.
Padberg, S; Mick, I; Frenzel, C; Greil, R; Hilberath, J; Schaefer, C;
Reprod Toxicol. 2017; 71: 146-149.
Fallberichte
Refractory plasmablastic lymphoma-a review of treatment options beyond standard therapy.
Pretscher, D; Kalisch, A; Wilhelm, M; Birkmann, J;
Ann Hematol. 2017; 96(6):967-970
Fallberichte
[Diagnosis and Management of Vestibular Schwannomas - An Interdisciplinary Challenge].
Rosahl, S; Bohr, C; Lell, M; Hamm, K; Iro, H;
Laryngorhinootologie. 2017; 96(S 01): S15-S182.
Originalarbeiten (Zeitschrift)
Azacitidine in adult patients with acute myeloid leukemia.
Schuh, AC; Dohner, H; Pleyer, L; Seymour, JF; Fenaux, P; Dombreth, H
CRIT REV ONCOL HEMAT. 2017; 116: 159-177.
Übersichtsarbeiten
Therapeutic Options for Recurrent High-Grade Gliomas: A Perspective Statement.
Schwartz, C; Thon, N; Winkler, PA;
World Neurosurg. 2017; 105: 985-987.
Letter
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial.
Sinn, M; Bahra, M; Liersch, T; Gellert, K; Messmann, H; Bechstein, W; Waldschmidt, D; Jacobasch, L; Wilhelm, M; Rau, BM; Grutzmann, R; Weinmann, A; Maschmeyer, G; Pelzer, U; Stieler, JM; Striefler, JK; Ghadimi, M; Bischoff, S; Dorken, B; Oettle, H; Riess, H
J CLIN ONCOL. 2017; 35(29): 3330-3337.
Originalarbeiten (Zeitschrift)
[Overweight and obesity are risk factors for development of cardiotoxicity from anthracyclines or sequential administration of anthracyclines and trastuzumab].
Wilhelm, M;
Strahlenther Onkol. 2017; 193(3): 234-235.
Kommentare
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Wöll, E; Thaler, J; Keil, F; Gruenberger, B; Hejna, M; Eisterer, W; Fridrik, MA; Ulmer, H; Trommet, V; Huemer, F; Weiss, L; Greil, R;
Anticancer Res. 2017; 37(10): 5553-5558.
Originalarbeiten (Zeitschrift)
DART-bid for loco-regionally advanced NSCLC
Wurstbauer, K; Zehentmayr, F; Deutschmann, H; Dagn, K; Exeli, AK; Kopp, P; Porsch, P; Maurer, B; Studnicka, M; Sedlmayer, F
STRAHLENTHER ONKOL. 2017; 193(4): 315-323.
Originalarbeiten (Zeitschrift)
The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance.
Alidzanovic, L; Starlinger, P; Schauer, D; Maier, T; Feldman, A; Buchberger, E; Stift, J; Koeck, U; Pop, L; Gruenberger, B; Gruenberger, T; Brostjan, C;
Oncotarget. 2016; 7(35):5719-57212
Originalarbeiten (Zeitschrift)
A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients.
Biehl, LM; Huth, A; Panse, J; Krämer, C; Hentrich, M; Engelhardt, M; Schäfer-Eckart, K; Kofla, G; Kiehl, M; Wendtner, CM; Karthaus, M; Ullmann, AJ; Hellmich, M; Christ, H; Vehreschild, MJ;
Ann Oncol. 2016; 27(10): 1916-1922.
Originalarbeiten (Zeitschrift)
DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial.
Boige, V; Vincent, M; Alexandre, P; Tejpar, S; Landolfi, S; Le Malicot, K; Greil, R; Cuyle, PJ; Yilmaz, M; Faroux, R; Matzdorff, A; Salazar, R; Lepage, C; Taieb, J; Laurent-Puig, P;
JAMA Oncol. 2016; 2(5):655-662
Originalarbeiten (Zeitschrift)
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
Böll, B; Goergen, H; Behringer, K; Bröckelmann, PJ; Hitz, F; Kerkhoff, A; Greil, R; von Tresckow, B; Eichenauer, DA; Bürkle, C; Borchmann, S; Fuchs, M; Diehl, V; Engert, A; Borchmann, P;
Blood. 2016; 127(18):218-292
Originalarbeiten (Zeitschrift)
Diagnostic challenges in vacuolar myelopathy: a didactic case report.
Ernst, F; Klausner, F; Kleindienst, W; Bartsch, H; Taylor, N; Trinka, E;
Spinal Cord Ser Cases. 2016; 2: 16020
Fallberichte
Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.
Fastner, G; Hauser-Kronberger, C; Moder, A; Reitsamer, R; Zehentmayr, F; Kopp, P; Fussl, C; Fischer, T; Deutschmann, H; Sedlmayer, F;
Strahlenther Onkol. 2016; 192(1): 1-7.
Originalarbeiten (Zeitschrift)
How to prevent a pacemaker implantation after sutureless bioprosthesis.
Fischlein, T; Gersak, B; Pfeiffer, S
J THORAC CARDIOV SUR. 2016; 152(2): 635-636.
Letter
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik, MA; Jaeger, U; Petzer, A; Willenbacher, W; Keil, F; Lang, A; Andel, J; Burgstaller, S; Krieger, O; Oberaigner, W; Sihorsch, K; Greil, R;
Eur J Cancer. 2016; 58:-21
Originalarbeiten (Zeitschrift)
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
Gass, P; Fasching, PA; Fehm, T; de Waal, J; Rezai, M; Baier, B; Baake, G; Kolberg, HC; Guggenberger, M; Warm, M; Harbeck, N; Wuerstlein, R; Deuker, JU; Dall, P; Richter, B; Wachsmann, G; Brucker, C; Siebers, JW; Fersis, N; Kuhn, T; Wolf, C; Vollert, HW; Breitbach, GP; Janni, W; Landthaler, R; Kohls, A; Rezek, D; Noesselt, T; Fischer, G; Henschen, S; Praetz, T; Heyl, V; Kuhn, T; Krauss, T; Thomssen, C; Hohn, A; Tesch, H; Mundhenke, C; Hein, A; Rauh, C; Bayer, CM; Jacob, A; Schmidt, K; Belleville, E; Hadji, P; Brucker, SY; Beckmann, MW; Wallwiener, D; Kummel, S; Lohberg, CR
BREAST CARE. 2016; 11(5): 315-322.
Originalarbeiten (Zeitschrift)
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.
Greil, R; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Fridrik, M; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Pleyer, L; Melchardt, T; Klingler, A; Mayer, J; Egle, A;
Lancet Haematol. 2016; 3(7):e317-e329
Originalarbeiten (Zeitschrift)
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis.
Heppt, MV; Eigentler, TK; Kahler, KC; Herbst, RA; Goppner, D; Gambichler, T; Ulrich, J; Dippel, E; Loquai, C; Schell, B; Schilling, B; Schad, SG; Schultz, ES; Matheis, F; Tietze, JK; Berking, C
Cancer Immunol Immunother. 2016; 65(8):951-959
Originalarbeiten (Zeitschrift)
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Hermine, O; Hoster, E; Walewski, J; Bosly, A; Stilgenbauer, S; Thieblemont, C; Szymczyk, M; Bouabdallah, R; Kneba, M; Hallek, M; Salles, G; Feugier, P; Ribrag, V; Birkmann, J; Forstpointner, R; Haioun, C; Hänel, M; Casasnovas, RO; Finke, J; Peter, N; Bouabdallah, K; Sebban, C; Fischer, T; Dührsen, U; Metzner, B; Maschmeyer, G; Kanz, L; Schmidt, C; Delarue, R; Brousse, N; Klapper, W; Macintyre, E; Delfau-Larue, MH; Pott, C; Hiddemann, W; Unterhalt, M; Dreyling, M;
Lancet. 2016; 388(10044): 565-575.
Originalarbeiten (Zeitschrift)
Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Hoda, MA; Klikovits, T; Arns, M; Dieckmann, K; Zöchbauer-Müller, S; Geltner, C; Baumgartner, B; Errhalt, P; Machan, B; Pohl, W; Hutter, J; Eckmayr, J; Studnicka, M; Flicker, M; Cerkl, P; Klepetko, W;
Wien Klin Wochenschr. 2016; 128(17-18): 618-626.
Originalarbeiten (Zeitschrift)
Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy.
Houédé, N; Locker, G; Lucas, C; Parra, HS; Basso, U; Spaeth, D; Tambaro, R; Basterretxea, L; Morelli, F; Theodore, C; Lusuardi, L; Lainez, N; Guillot, A; Tonini, G; Bielle, J; Del Muro, XG;
BMC Cancer. 2016; 16(1):752
Originalarbeiten (Zeitschrift)
Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database.
Klikovits, T; Hoda, MA; Dong, Y; Arns, M; Baumgartner, B; Errhalt, P; Geltner, C; Machan, B; Pohl, W; Hutter, J; Eckmayr, J; Studnicka, M; Flicker, M; Cerkl, P; Kirchbacher, K; Klepetko, W;
Wien Klin Wochenschr. 2016; 128(17-18): 627-634.
Originalarbeiten (Zeitschrift)
Reference data on muscle volumes of healthy human pelvis and lower extremity muscles: an in vivo magnetic resonance imaging feasibility study.
Lube, J; Cotofana, S; Bechmann, I; Milani, TL; Özkurtul, O; Sakai, T; Steinke, H; Hammer, N;
Surg Radiol Anat. 2016; 38(1): 97-106.
Originalarbeiten (Zeitschrift)
European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer.
Marguet, S; Mazouni, C; Ramaekers, BL; Dunant, A; Kates, R; Jacobs, VR; Joore, MA; Harbeck, N; Bonastre, J;
Eur J Cancer. 2016; 63: 168-179.
Originalarbeiten (Zeitschrift)
Mesonephric adenocarcinoma of the vagina : Diagnosis and multimodal treatment of a rare tumor and analysis of worldwide experience.
Mueller, I; Kametriser, G; Jacobs, VR; Bogner, G; Staudach, A; Koch, H; Wolfrum-Ristau, P; Schausberger, C; Fischer, T; Sedlmayer, F;
Strahlenther Onkol. 2016; 192(9): 668-671.
Fallberichte
[Standardisation of the Initial Treatment of Severely Burned Patients: The Necessary Transfer of Concepts from Trauma Care].
Münzberg, M; Harbers, T; Kneser, U; Grützner, PA; Reichert, B; Kremer, T; Wölfl, CG; Horter, J; Hirche, C;
Zentralbl Chir. 2016; 141(6):654-659
Originalarbeiten (Zeitschrift)
Vascular complications in plating of the proximal femur: review.
Neubauer, T; Grechenig, S; Leitner, L; Auffarth, A; Plecko, M;
Arch Orthop Trauma Surg. 2016; 136(4): 539-551.
Originalarbeiten (Zeitschrift)
Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancer.
Ponholzer, A; Loidl, W; Bektic, J; Dorfinger, K; Hruby, S; Jeschke, K; Kramer, G; Krause, S; Ludvik, G; Remzi, M; Roider, M; Stoiber, F;
Wien Klin Wochenschr. 2016; 128(3-4):156-163
Originalarbeiten (Zeitschrift)
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M;
Br J Cancer. 2016; 115(10):1264-1272
Originalarbeiten (Zeitschrift)
Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group.
Sasse, S; Alram, M; Müller, H; Smardová, L; Metzner, B; Doehner, H; Fischer, T; Niederwieser, DW; Schmitz, N; Schäfer-Eckart, K; Raemaekers, JM; Schmalz, O; Tresckow, BV; Engert, A; Borchmann, P;
Leuk Lymphoma. 2016; 57(5):1067-1073
Originalarbeiten (Zeitschrift)
Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response.
Schauer, D; Starlinger, P; Alidzanovic, L; Zajc, P; Maier, T; Feldman, A; Padickakudy, R; Buchberger, E; Elleder, V; Spittler, A; Stift, J; Pop, L; Gruenberger, B; Gruenberger, T; Brostjan, C;
Oncoimmunology. 2016; 5(6):e1160185
Originalarbeiten (Zeitschrift)
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Straka, C; Liebisch, P; Salwender, H; Hennemann, B; Metzner, B; Knop, S; Adler-Reichel, S; Gerecke, C; Wandt, H; Bentz, M; Bruemmendorf, TH; Hentrich, M; Pfreundschuh, M; Wolf, HH; Sezer, O; Bargou, R; Jung, W; Trümper, L; Hertenstein, B; Heidemann, E; Bernhard, H; Lang, N; Frickhofen, N; Hebart, H; Schmidmaier, R; Sandermann, A; Dechow, T; Reichle, A; Schnabel, B; Schäfer-Eckart, K; Langer, C; Gramatzki, M; Hinke, A; Emmerich, B; Einsele, H;
Haematologica. 2016; 101(11): 1398-1406.
Originalarbeiten (Zeitschrift)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.
Suker, M; Beumer, BR; Sadot, E; Marthey, L; Faris, JE; Mellon, EA; El-Rayes, BF; Wang-Gillam, A; Lacy, J; Hosein, PJ; Moorcraft, SY; Conroy, T; Hohla, F; Allen, P; Taieb, J; Hong, TS; Shridhar, R; Chau, I; van Eijck, CH; Koerkamp, BG
Lancet Oncol. 2016; 17(6):801-810
Übersichtsarbeiten
Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates.
Van der Ven, H; Liebenthron, J; Beckmann, M; Toth, B; Korell, M; Krüssel, J; Frambach, T; Kupka, M; Hohl, MK; Winkler-Crepaz, K; Seitz, S; Dogan, A; Griesinger, G; Häberlin, F; Henes, M; Schwab, R; Sütterlin, M; von Wolff, M; Dittrich, R;
Hum Reprod. 2016; 31(9):203-241
Originalarbeiten (Zeitschrift)
Adjuvant medical treatment for breast cancer in elderly and old women
Westphal, T; Rinnerthaler, G; Mlineritsch, B
MEMO-MAG EUR MED ONC. 2016; 9(1): 17-19.
Übersichtsarbeiten
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice.
Wilhelm, M; Mueller, L; Miller, MC; Link, K; Holdenrieder, S; Bertsch, T; Kunzmann, V; Stoetzer, OJ; Suttmann, I; Braess, J; Birkmann, J; Roessler, M; Moritz, B; Kraff, S; Salamone, SJ; Jaehde, U;
Clin Colorectal Cancer. 2016; 15(4):381-388
Originalarbeiten (Zeitschrift)
S3-Guideline of the German Society for Nutritional Medicine (DGEM) in Cooperation with the DGHO, the ASORS and the AKE Clinical Nutrition in Oncology
Arends, J; Bertz, H; Bischoff, SC; Fietkau, R; Herrmann, HJ; Holm, E; Horneber, M; Hutterer, E; Korber, J; Schmid, I
AKTUEL ERNAHRUNGSMED. 2015; 40(5): E1-E74.
Originalarbeiten (Zeitschrift)
Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
Coates, AS; Winer, EP; Goldhirsch, A; Gelber, RD; Gnant, M; Piccart-Gebhart, M; Thürlimann, B; Senn, HJ;
Ann Oncol. 2015; 26(8):1533-1546
Originalarbeiten (Zeitschrift)
Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany.
Dall, P; Lenzen, G; Göhler, T; Lerchenmüller, C; Feisel-Schwickardi, G; Koch, T; Eggert, J; Heilmann, V; Schindler, C; Wilke, J; Tesch, H; Selbach, J; Wohlfarth, T; Eustermann, H; Hinke, A;
J Geriatr Oncol. 2015; 6(6):462-469
Originalarbeiten (Zeitschrift)
IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner, G; Reitsamer, R; Ziegler, I; Zehentmayr, F; Fussl, C; Kopp, P; Peintinger, F; Greil, R; Fischer, T; Deutschmann, H; Sedlmayer, F;
Int J Cancer. 2015; 136(5):1193-1201
Originalarbeiten (Zeitschrift)
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J;
Ann Oncol. 2015; 26(8):1685-1691
Originalarbeiten (Zeitschrift)
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
Höfner, T; Vallet, S; Hadaschik, BA; Pahernik, S; Duensing, S; Hohenfellner, M; Jäger, D; Grüllich, C;
World J Urol. 2015; 33(6): 833-839.
Originalarbeiten (Zeitschrift)
Comparison of 231 patients receiving either "pull-through" or "push" percutaneous endoscopic gastrostomy.
Köhler, G; Kalcher, V; Koch, OO; Luketina, RR; Emmanuel, K; Spaun, G;
Surg Endosc. 2015; 29(1):170-175
Originalarbeiten (Zeitschrift)
Minimally Invasive Retroperitoneal Lymphadenectomy: Current Status.
Kunit, T; Janetschek, G;
Urol Clin North Am. 2015; 42(3): 321-329.
Übersichtsarbeiten
Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.
Mayr, C; Neureiter, D; Pichler, M; Berr, F; Wagner, A; Kiesslich, T; Namberger, K;
Mol Med Rep. 2015; 12(2):2247-2252
Originalarbeiten (Zeitschrift)
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer.
Melchardt, T; Hufnagl, C; Magnes, T; Weiss, L; Hutarew, G; Neureiter, D; Schlattau, A; Moser, G; Gaggl, A; Tränkenschuh, W; Greil, R; Egle, A;
BMC Cancer. 2015; 15:725
Originalarbeiten (Zeitschrift)
Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
Nachbaur, D; Angelova, O; Orth-Holler, D; Ditlbacher, A; Lackner, M; Auberger, J; Lass-Florl, C
EUR J HAEMATOL. 2015; 94(3): 258-264.
Originalarbeiten (Zeitschrift)
Esthesioneuroblastoma With Poor Outcome Despite Extensive Treatment.
Niyaz, L; Gunduz, K; Meco, C; Kankaya, D;
J Craniofac Surg. 2015; 26(7): e615-e616.
Fallberichte
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement.
Petru, E; Singer, CF; Polterauer, S; Galid, A; Schauer, C; Klocker, J; Seifert, M; Reinthaller, A; Benedicic, C; Hubalek, M; Hefler, L; Marth, C; Scholl-Firon, T; Bogner, G; Zeimet, AG
Wien Med Wochenschr. 2015; 165(19-20):387-394
Übersichtsarbeiten
Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.
Provenzano, E; Bossuyt, V; Viale, G; Cameron, D; Badve, S; Denkert, C; MacGrogan, G; Penault-Llorca, F; Boughey, J; Curigliano, G; Dixon, JM; Esserman, L; Fastner, G; Kuehn, T; Peintinger, F; von Minckwitz, G; White, J; Yang, W; Symmans, WF;
Mod Pathol. 2015; 28(9):1185-1201
Originalarbeiten (Zeitschrift)
Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.
Rendl, G; Rettenbacher, L; Holzmannhofer, J; Datz, L; Hauser-Kronberger, C; Fastner, G; Ofner, D; Sedlmayer, F; Pirich, C;
Ann Nucl Med. 2015; 29(3): 284-294.
Originalarbeiten (Zeitschrift)
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel, C; Graeven, U; Fietkau, R; Hohenberger, W; Hothorn, T; Arnold, D; Hofheinz, RD; Ghadimi, M; Wolff, HA; Lang-Welzenbach, M; Raab, HR; Wittekind, C; Ströbel, P; Staib, L; Wilhelm, M; Grabenbauer, GG; Hoffmanns, H; Lindemann, F; Schlenska-Lange, A; Folprecht, G; Sauer, R; Liersch, T;
Lancet Oncol. 2015; 16(8): 979-989.
Originalarbeiten (Zeitschrift)
T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy.
Schmid, D; Grabmer, C; Streif, D; Lener, T; Schallmoser, K; Rohde, E;
Vox Sang. 2015; 108(1):82-88
Originalarbeiten (Zeitschrift)
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML-long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)†.
Thiel, A; Schetelig, J; Pönisch, W; Schäfer-Eckart, K; Aulitzky, W; Peter, N; Schulze, A; Maschmeyer, G; Neugebauer, S; Herbst, R; Hänel, A; Morgner, A; Kroschinsky, F; Bornhäuser, M; Lange, T; Wilhelm, M; Niederwieser, D; Ehninger, G; Fiedler, F; Hänel, M;
Ann Oncol. 2015; 26(7): 143-140.
Originalarbeiten (Zeitschrift)
Carboplatin and Nonpegylated Liposomal Doxorubicin in Primary Advanced or Recurrent Endometrial Cancer: A Phase 2 Trial Conducted by AGO Austria.
Volgger, B; Zeimet, AG; Reinthaller, A; Petru, E; Schauer, C; Klein, M; Sevelda-Schwarzgruber, U; Bogner, G; Wolfram, G; Marth, C;
Int J Gynecol Cancer. 2015; 25(2): 257-262.
Originalarbeiten (Zeitschrift)
Prenatal maternal stress predicts stress reactivity at 2½ years of age: The Iowa Flood Study.
Yong Ping, E; Laplante, DP; Elgbeili, G; Hillerer, KM; Brunet, A; O"Hara, MW; King, S;
Psychoneuroendocrinology. 2015; 56: 62-78.
Originalarbeiten (Zeitschrift)
Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
Zehentmayr, F; Söhn, M; Exeli, AK; Wurstbauer, K; Tröller, A; Deutschmann, H; Fastner, G; Fussl, C; Steininger, P; Kranzinger, M; Belka, C; Studnicka, M; Sedlmayer, F;
Radiat Oncol. 2015; 10(1): 121
Originalarbeiten (Zeitschrift)
Thromboelastometric Monitoring of the Hemostatic Effect of Platelet Concentrates Transfusion in Thrombocytopenic Children Undergoing Chemotherapy.
Ziegler, B; Solomon, C; Cadamuro, J; Jones, N;
Clin Appl Thromb Hemost. 2015; 21(6): 558-564.
Originalarbeiten (Zeitschrift)
Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T;
Anticancer Drugs. 2014; 25(7): 848-853.
Originalarbeiten (Zeitschrift)
Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009.
Burney, P; Jithoo, A; Kato, B; Janson, C; Mannino, D; Nizankowska-Mogilnicka, E; Studnicka, M; Tan, W; Bateman, E; Kocabas, A; Vollmer, WM; Gislason, T; Marks, G; Koul, PA; Harrabi, I; Gnatiuc, L; Buist, S
Thorax. 2014; 69(3):269-273
Originalarbeiten (Zeitschrift)
Darbepoetin inhibits proliferation of hepatic cancer cells in the presence of TGF-β.
Ehnert, S; Freude, T; Eicher, C; Burkhardt, B; Martínez Sánchez, JJ; Neumann, J; Mühl-Benninghaus, R; Dooley, S; Pscherer, S; Nussler, AK;
Arch Toxicol. 2014; 88(1): 89-96.
Originalarbeiten (Zeitschrift)
Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Eisterer, W; De Vries, A; Öfner, D; Rabl, H; Koplmüller, R; Greil, R; Tschmelitsch, J; Schmid, R; Kapp, K; Lukas, P; Sedlmayer, F; Höfler, G; Gnant, M; Thaler, J;
Anticancer Res. 2014; 34(11):676-673
Originalarbeiten (Zeitschrift)
Effects of 24h working on-call on psychoneuroendocrine and oculomotor function: A randomized cross-over trial.
Ernst, F; Rauchenzauner, M; Zoller, H; Griesmacher, A; Hammerer-Lercher, A; Carpenter, R; Schuessler, G; Joannidis, M;
Psychoneuroendocrinology. 2014; 47: 221-231.
Originalarbeiten (Zeitschrift)
Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases.
Evrard, S; Poston, G; Kissmeyer-Nielsen, P; Diallo, A; Desolneux, G; Brouste, V; Lalet, C; Mortensen, F; Stättner, S; Fenwick, S; Malik, H; Konstantinidis, I; DeMatteo, R; D"Angelica, M; Allen, P; Jarnagin, W; Mathoulin-Pelissier, S; Fong, Y;
PLoS One. 2014; 9(12): e114404
Originalarbeiten (Zeitschrift)
Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.
Gampenrieder, SP; Romeder, F; Muß, C; Pircher, M; Ressler, S; Rinnerthaler, G; Bartsch, R; Sattlberger, C; Mlineritsch, B; Greil, R;
Anticancer Res. 2014; 34(1): 227-233.
Originalarbeiten (Zeitschrift)
Preparing for prospective clinical trials: a national initiative of an excellence registry for consecutive pancreatic cancer resections.
Gangl, O; Sahora, K; Kornprat, P; Margreiter, C; Primavesi, F; Bareck, E; Schindl, M; Längle, F; Ofner, D; Mischinger, HJ; Pratschke, J; Gnant, M; Függer, R;
World J Surg. 2014; 38(2): 45-62.
Originalarbeiten (Zeitschrift)
The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by "on-demand" addition of plerixafor to granulocyte-colony-stimulating factor.
Girbl, T; Lunzer, V; Greil, R; Namberger, K; Hartmann, TN
TRANSFUSION. 2014; 54(9): 2325-2335.
Originalarbeiten (Zeitschrift)
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Gnant, M; Filipits, M; Greil, R; Stoeger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Knauer, M; Singer, C; Jakesz, R; Dubsky, P; Fitzal, F; Bartsch, R; Steger, G; Balic, M; Ressler, S; Cowens, JW; Storhoff, J; Ferree, S; Schaper, C; Liu, S; Fesl, C; Nielsen, TO;
Ann Oncol. 2014; 25(2): 339-345.
Originalarbeiten (Zeitschrift)
Pediatric tectal plate gliomas: clinical and radiological progression, MR imaging characteristics, and management of hydrocephalus.
Griessenauer, CJ; Rizk, E; Miller, JH; Hendrix, P; Tubbs, RS; Dias, MS; Riemenschneider, K; Chern, JJ;
J Neurosurg Pediatr. 2014; 13(1): 13-20.
Originalarbeiten (Zeitschrift)
Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.
Heitzer, E; Artl, M; Filipits, M; Resel, M; Graf, R; Weißenbacher, B; Lax, S; Gnant, M; Wrba, F; Greil, R; Dietze, O; Hofbauer, F; Böhm, G; Höfler, G; Samonigg, H; Schaberl-Moser, R; Balic, M; Dandachi, N;
Mod Pathol. 2014; 27(6): 906-915.
Originalarbeiten (Zeitschrift)
Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.
Hohla, F; Hopfinger, G; Romeder, F; Rinnerthaler, G; Bezan, A; Stättner, S; Hauser-Kronberger, C; Ulmer, H; Greil, R;
Int J Oncol. 2014; 44(1):319-326
Originalarbeiten (Zeitschrift)
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
Jacamo, R; Chen, Y; Wang, Z; Ma, W; Zhang, M; Spaeth, EL; Wang, Y; Battula, VL; Mak, PY; Schallmoser, K; Ruvolo, P; Schober, WD; Shpall, EJ; Nguyen, MH; Strunk, D; Bueso-Ramos, CE; Konoplev, S; Davis, RE; Konopleva, M; Andreeff, M;
Blood. 2014; 123(17): 2691-2702.
Originalarbeiten (Zeitschrift)
Controversies in the oncosurgical management of liver limited stage IV colorectal cancer.
Jones, RP; Stättner, S; Sutton, P; Dunne, DF; McWhirter, D; Fenwick, SW; Malik, HZ; Poston, GJ;
Surg Oncol. 2014; 23(2):53-60
Übersichtsarbeiten
Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.
Kiesslich, T; Mayr, C; Wachter, J; Bach, D; Fuereder, J; Wagner, A; Alinger, B; Pichler, M; Di Fazio, P; Ocker, M; Berr, F; Neureiter, D;
Mol Cell Biochem. 2014; 396(1-2):257-268
Originalarbeiten (Zeitschrift)
From the nucleus to the plasma membrane: translocation of the nuclear proteins histone H3 and lamin B1 in apoptotic microglia.
Klein, B; Lütz-Meindl, U; Kerschbaum, HH;
Apoptosis. 2014; 19(5): 759-775.
Originalarbeiten (Zeitschrift)
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
Kocher, F; Pircher, A; Mohn-Staudner, A; Romeder, F; Duller, W; Steinmaurer, M; Eckmayr, J; Schmid, T; Hilbe, W; Fiegl, M; Greil, R
LUNG CANCER. 2014; 85(3): 395-400.
Originalarbeiten (Zeitschrift)
Laparoscopic and robotic postchemotherapy retroperitoneal lymph node dissection.
Kunit, T; Janetschek, G;
Curr Opin Urol. 2014; 24(2): 162-167.
Originalarbeiten (Zeitschrift)
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.
Kwon, ED; Drake, CG; Scher, HI; Fizazi, K; Bossi, A; van den Eertwegh, AJ; Krainer, M; Houede, N; Santos, R; Mahammedi, H; Ng, S; Maio, M; Franke, FA; Sundar, S; Agarwal, N; Bergman, AM; Ciuleanu, TE; Korbenfeld, E; Sengeløv, L; Hansen, S; Logothetis, C; Beer, TM; McHenry, MB; Gagnier, P; Liu, D; Gerritsen, WR;
Lancet Oncol. 2014; 15(7): 700-712.
Originalarbeiten (Zeitschrift)
Liver toxicity during temozolomide chemotherapy caused by Chinese herbs.
Melchardt, T; Magnes, T; Weiss, L; Grundbichler, M; Strasser, M; Hufnagl, C; Moik, M; Greil, R; Egle, A;
BMC COMPLEM ALTERN M. 2014; 14: 115
Fallberichte
Multi-institutional Pooled Analysis on Adjuvant Chemoradiation in Pancreatic Cancer.
Morganti, AG; Falconi, M; van Stiphout, RG; Mattiucci, GC; Alfieri, S; Calvo, FA; Dubois, JB; Fastner, G; Herman, JM; Maidment, BW; Miller, RC; Regine, WF; Reni, M; Sharma, NK; Ippolito, E; Valentini, V;
Int J Radiat Oncol Biol Phys. 2014; 90(4):911-917
Originalarbeiten (Zeitschrift)
Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects.
Neureiter, D; Jäger, T; Ocker, M; Kiesslich, T;
World J Gastroenterol. 2014; 20(24): 7830-7848.
Übersichtsarbeiten
The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas.
Quint, K; Stiel, N; Neureiter, D; Schlicker, HU; Nimsky, C; Ocker, M; Strik, H; Kolodziej, MA;
Tumour Biol. 2014; 35(9): 897-889.
Originalarbeiten (Zeitschrift)
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Taieb, J; Tabernero, J; Mini, E; Subtil, F; Folprecht, G; Van Laethem, JL; Thaler, J; Bridgewater, J; Petersen, LN; Blons, H; Collette, L; Van Cutsem, E; Rougier, P; Salazar, R; Bedenne, L; Emile, JF; Laurent-Puig, P; Lepage, C;
Lancet Oncol. 2014; 15(8): 862-873.
Originalarbeiten (Zeitschrift)
Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.
Weiss, L; Melchardt, T; Habringer, S; Boekstegers, A; Hufnagl, C; Neureiter, D; Hopfinger, G; Greil, R; Egle, A;
Ann Oncol. 2014; 25(1):171-176
Originalarbeiten (Zeitschrift)
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells.
Wilhelm, M; Smetak, M; Schaefer-Eckart, K; Kimmel, B; Birkmann, J; Einsele, H; Kunzmann, V
J Transl Med. 2014; 12:45
Originalarbeiten (Zeitschrift)
Selenium action in neuro-oncology.
Yakubov, E; Buchfelder, M; Eyüpoglu, IY; Savaskan, NE;
Biol Trace Elem Res. 2014; 161(3):246-254
Übersichtsarbeiten
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.
Baselga, J; Gómez, P; Greil, R; Braga, S; Climent, MA; Wardley, AM; Kaufman, B; Stemmer, SM; Pêgo, A; Chan, A; Goeminne, JC; Graas, MP; Kennedy, MJ; Ciruelos Gil, EM; Schneeweiss, A; Zubel, A; Groos, J; Melezínková, H; Awada, A;
J Clin Oncol. 2013; 31(20):2586-2592
Originalarbeiten (Zeitschrift)
Measurement of natriuretic peptides at the point of care in the emergency and ambulatory setting: current status and future perspectives.
Bingisser, R; Cairns, CB; Christ, M; Collinson, P; Hausfater, P; Lindahl, B; Mair, J; Price, C; Venge, P;
Am Heart J. 2013; 166(4): 614-621.e1.
Übersichtsarbeiten
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.
Böll, B; Görgen, H; Fuchs, M; Pluetschow, A; Eich, HT; Bargetzi, MJ; Weidmann, E; Junghanß, C; Greil, R; Scherpe, A; Schmalz, O; Eichenauer, DA; von Tresckow, B; Rothe, A; Diehl, V; Engert, A; Borchmann, P;
J Clin Oncol. 2013; 31(12):1522-1529
Originalarbeiten (Zeitschrift)
Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer.
Brueckl, WM; Al-Batran, SE; Ficker, JH; Claas, S; Atmaca, A; Hartmann, A; Rieker, RJ; Wirtz, RM;
Int J Cancer. 2013; 133(8):1825-1831
Originalarbeiten (Zeitschrift)
Omega-3 poly-unsaturated fatty acids for the prevention of severe neutropenic enterocolitis in patients with acute myeloid leukemia.
Bükki, J; Stanga, Z; Tellez, FB; Duclos, K; Kolev, M; Krähenmann, P; Pabst, T; Iff, S; Jüni, P;
Nutr Cancer. 2013; 65(6): 83-42.
Originalarbeiten (Zeitschrift)
Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer.
Crown, JP; Diéras, V; Staroslawska, E; Yardley, DA; Bachelot, T; Davidson, N; Wildiers, H; Fasching, PA; Capitain, O; Ramos, M; Greil, R; Cognetti, F; Fountzilas, G; Blasinska-Morawiec, M; Liedtke, C; Kreienberg, R; Miller, WH; Tassell, V; Huang, X; Paolini, J; Kern, KA; Romieu, G;
J Clin Oncol. 2013; 31(23):2870-2878
Originalarbeiten (Zeitschrift)
Pegfilgrastim prophylaxis in patients at different levels of risk for chemotherapy-associated febrile neutropenia: an observational study.
Fiegl, M; Steger, GG; Studnicka, M; Eisterer, W; Jaeger, C; Willenbacher, W
Curr Med Res Opin. 2013; 29(5):50-15
Originalarbeiten (Zeitschrift)
Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study
Furthauer, J; Flamm, M; Sonnichsen, A
BMC FAM PRACT. 2013; 14: 47
Originalarbeiten (Zeitschrift)
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.
Gianni, L; Romieu, GH; Lichinitser, M; Serrano, SV; Mansutti, M; Pivot, X; Mariani, P; Andre, F; Chan, A; Lipatov, O; Chan, S; Wardley, A; Greil, R; Moore, N; Prot, S; Pallaud, C; Semiglazov, V;
J Clin Oncol. 2013; 31(14):1719-1725
Originalarbeiten (Zeitschrift)
The occurrence of dental caries is associated with atherosclerosis.
Glodny, B; Nasseri, P; Crismani, A; Schoenherr, E; Luger, AK; Bertl, K; Petersen, J
Clinics (Sao Paulo). 2013; 68(7):946-953
Originalarbeiten (Zeitschrift)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
Goldhirsch, A; Winer, EP; Coates, AS; Gelber, RD; Piccart-Gebhart, M; Thürlimann, B; Senn, HJ;
Ann Oncol. 2013; 24(9): 2206-2223.
Originalarbeiten (Zeitschrift)
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Hopfinger, G; Busch, R; Pflug, N; Weit, N; Westermann, A; Fink, AM; Cramer, P; Reinart, N; Winkler, D; Fingerle-Rowson, G; Stilgenbauer, S; Döhner, H; Kandler, G; Eichhorst, B; Hallek, M; Herling, M;
Cancer. 2013; 119(12):2258-2267
Originalarbeiten (Zeitschrift)
Prospective multi-center study for quantification of chemotherapies and CTX-related direct medication costs avoided by use of biomarkers uPA and PAI-1 in primary breast cancer.
Jacobs, VR; Augustin, D; Wischnik, A; Kiechle, M; Höss, C; Steinkohl, O; Rack, B; Kapitza, T; Krase, P;
Breast. 2013; 22(4):436-443
Originalarbeiten (Zeitschrift)
Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancer.
Jacobs, VR; Kates, RE; Kantelhardt, E; Vetter, M; Wuerstlein, R; Fischer, T; Schmitt, M; Jaenicke, F; Untch, M; Thomssen, C; Harbeck, N;
Breast Cancer Res Treat. 2013; 138(3):839-850
Originalarbeiten (Zeitschrift)
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
Keil, F; Selzer, E; Berghold, A; Reinisch, S; Kapp, KS; De Vries, A; Greil, R; Bachtiary, B; Tinchon, C; Anderhuber, W; Burian, M; Kasparek, AK; Elsäßer, W; Kainz, H; Riedl, R; Kopp, M; Kornek, G;
Eur J Cancer. 2013; 49(2):352-359
Originalarbeiten (Zeitschrift)
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas.
Korfel, A; Elter, T; Thiel, E; Hänel, M; Möhle, R; Schroers, R; Reiser, M; Dreyling, M; Eucker, J; Scholz, C; Metzner, B; Röth, A; Birkmann, J; Schlegel, U; Martus, P; Illerhaus, G; Fischer, L;
Haematologica. 2013; 98(3): 364-370.
Originalarbeiten (Zeitschrift)
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Kubicka, S; Greil, R; André, T; Bennouna, J; Sastre, J; Van Cutsem, E; von Moos, R; Osterlund, P; Reyes-Rivera, I; Müller, T; Makrutzki, M; Arnold, D;
Ann Oncol. 2013; 24(9):2342-2349
Originalarbeiten (Zeitschrift)
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.
Lang, I; Brodowicz, T; Ryvo, L; Kahan, Z; Greil, R; Beslija, S; Stemmer, SM; Kaufman, B; Zvirbule, Z; Steger, GG; Melichar, B; Pienkowski, T; Sirbu, D; Messinger, D; Zielinski, C;
Lancet Oncol. 2013; 14(2):125-133
Originalarbeiten (Zeitschrift)
Care complexity, mood, and quality of life in liver pre-transplant patients.
Lobo, E; Stiefel, F; Söllner, W; Santabarbara, J; Lobo, A; Huyse, F; Marcos, G; Michaud, L; Hohenberger, W; Ludwig, G;
Clin Transplant. 2013; 27(3): 417-425.
Originalarbeiten (Zeitschrift)
Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.
Melchardt, T; Weiss, L; Pleyer, L; Steinkirchner, S; Auberger, J; Hopfinger, G; Greil, R; Egle, A;
Oncol Lett. 2013; 6(6):1756-1758
Originalarbeiten (Zeitschrift)
Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement.
Pircher, A; Wasle, IK; Mian, M; Gamerith, G; Ulsperger, E; Studnicka, M; Mohn-Staudner, A; Hilbe, W; Fiegl, M
ANTICANCER RES. 2013; 33(9): 3831-3836.
Originalarbeiten (Zeitschrift)
Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
Pleyer, L; Stauder, R; Burgstaller, S; Schreder, M; Tinchon, C; Pfeilstocker, M; Steinkirchner, S; Melchardt, T; Mitrovic, M; Girschikofsky, M; Lang, A; Krippl, P; Sliwa, T; Egle, A; Linkesch, W; Voskova, D; Angermann, H; Greil, R;
J Hematol Oncol. 2013; 6:32
Editorials
Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons.
Staff, NP; Podratz, JL; Grassner, L; Bader, M; Paz, J; Knight, AM; Loprinzi, CL; Trushina, E; Windebank, AJ;
Neurotoxicology. 2013; 39: 124-131.
Originalarbeiten (Zeitschrift)
Osteosarcoma of the mobile spine
Zils, K; Bielack, S; Wilhelm, M; Werner, M; Schwarz, R; Windhager, R; Hofmann-Wackersreuther, G; Andus, T; Kager, L; Kuehne, T; Reichardt, P; von Kalle, T
ANN ONCOL. 2013; 24(8): 2190-2195.
Originalarbeiten (Zeitschrift)
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).
Aapro, M; Molassiotis, A; Dicato, M; Peláez, I; Rodríguez-Lescure, Á; Pastorelli, D; Ma, L; Burke, T; Gu, A; Gascon, P; Roila, F;
Ann Oncol. 2012; 23(8):1986-1992
Originalarbeiten (Zeitschrift)
A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis.
Campa, D; Müller, P; Edler, L; Knoefel, L; Barale, R; Heussel, CP; Thomas, M; Canzian, F; Risch, A;
Int J Cancer. 2012; 131(12):2920-2928
Originalarbeiten (Zeitschrift)
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
Dubsky, PC; Jakesz, R; Mlineritsch, B; Pöstlberger, S; Samonigg, H; Kwasny, W; Tausch, C; Stöger, H; Haider, K; Fitzal, F; Singer, CF; Stierer, M; Sevelda, P; Luschin-Ebengreuth, G; Taucher, S; Rudas, M; Bartsch, R; Steger, GG; Greil, R; Filipcic, L; Gnant, M;
J CLIN ONCOL. 2012; 30(7): 722-728.
Originalarbeiten (Zeitschrift)
Multifocal epithelioid hemangioendothelioma derived from the spine region: case report and literature review.
Kerry, G; Marx, O; Kraus, D; Vogel, M; Kaiser, A; Ruedinger, C; Steiner, HH;
Case Rep Oncol. 2012; 5(1): 91-98.
Originalarbeiten (Zeitschrift)
First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.
Köhne, CH; Hofheinz, R; Mineur, L; Letocha, H; Greil, R; Thaler, J; Fernebro, E; Gamelin, E; Decosta, L; Karthaus, M;
J Cancer Res Clin Oncol. 2012; 138(1):65-72
Originalarbeiten (Zeitschrift)
The positive non-sentinel status is not the main decisional factor for chemotherapy assignment in breast cancer with micrometastatic disease in the sentinel lymph node.
Mazouni, C; Reitsamer, R; Rimareix, F; Stranzl, H; Uzan, C; Garbay, JR; Delaloge, S; Peintinger, F;
J Surg Oncol. 2012; 106(6):703-707
Originalarbeiten (Zeitschrift)
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
Rödel, C; Liersch, T; Becker, H; Fietkau, R; Hohenberger, W; Hothorn, T; Graeven, U; Arnold, D; Lang-Welzenbach, M; Raab, HR; Sülberg, H; Wittekind, C; Potapov, S; Staib, L; Hess, C; Weigang-Köhler, K; Grabenbauer, GG; Hoffmanns, H; Lindemann, F; Schlenska-Lange, A; Folprecht, G; Sauer, R;
Lancet Oncol. 2012; 13(7): 679-687.
Originalarbeiten (Zeitschrift)
Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Schlick, K; Aigelsreiter, A; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W
Onkologie. 2012; 35(7-8):447-450
Fallberichte
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study
Wandt, H; Schaefer-Eckart, K; Wendelin, K; Pilz, B; Wilhelm, M; Thalheimer, M; Mahlknecht, U; Ho, A; Schaich, M; Kramer, M; Kaufmann, M; Leimer, L; Schwerdtfeger, R; Conradi, R; Dolken, G; Klenner, A; Hanel, M; Herbst, R; Junghanss, C; Ehninger, G
LANCET. 2012; 380(9850): 1309-1316.
Originalarbeiten (Zeitschrift)
[Radiotherapy of rectal cancer].
Wolf, M; Zehentmayr, F; Belka, C;
Radiologe. 2012; 52(6): 545-549.
Originalarbeiten (Zeitschrift)
Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre.
Wolf, MC; Zehentmayr, F; Schmidt, M; Hölzel, D; Belka, C;
Radiat Oncol. 2012; 7: 60
Originalarbeiten (Zeitschrift)
[Extrahepatic cholangiocarcinoma: current state of palliation therapy].
Wolkersdörfer, GW; Berr, F; Nawara, C; Emmanuel, K;
Zentralbl Chir. 2012; 137(6): 522-526.
Übersichtsarbeiten
Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy Diagnostic value and the work-up of sentinel node negative patients
Dalus, K; Reitsamer, R; Holzmannhofer, J; Rendl, G; Pirich, C; Kronberger, C; Rettenbacher, L
NUKLEARMED-NUCL MED. 2011; 50(1): 33-38.
Originalarbeiten (Zeitschrift)
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Davies, C; Godwin, J; Gray, R; Clarke, M; Cutter, D; Darby, S; McGale, P; Pan, HC; Taylor, C; Wang, YC; Dowsett, M; Ingle, J; Peto, R;
Lancet. 2011; 378(9793): 771-784.
Originalarbeiten (Zeitschrift)
Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II study.
Eisterer, W; DE Vries, A; Kendler, D; Spechtenhauser, B; Königsrainer, A; Nehoda, H; Virgolini, I; Lukas, P; Bechter, O; Wöll, E; Ofner, D;
Anticancer Res. 2011; 31(12): 4407-4412.
Originalarbeiten (Zeitschrift)
Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients.
Fiegl, M; Falkner, F; Steurer, M; Zojer, N; Hopfinger, G; Haslbauer, F; Winder, G; Voskova, D; Andel, J; Lang, A; Brychtova, Y; Mayer, J; Greil, R; Gastl, G;
Ann Hematol. 2011; 90(9):1083-1091
Originalarbeiten (Zeitschrift)
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer.
Fischer von Weikersthal, L; Schalhorn, A; Stauch, M; Quietzsch, D; Maubach, PA; Lambertz, H; Oruzio, D; Schlag, R; Weigang-Köhler, K; Vehling-Kaiser, U; Schulze, M; Truckenbrodt, J; Goebeler, M; Mittermüller, J; Bosse, D; Szukics, B; Grundeis, M; Zwingers, T; Giessen, C; Heinemann, V;
Eur J Cancer. 2011; 47(2): 206-214.
Originalarbeiten (Zeitschrift)
Financial Quality Control of In-Patient Chemotherapy in Germany: Are Additional Payments Cost-Covering for Pharmaco-Oncological Expenses?
Jacobs, VR; Mallmann, P;
Breast Care (Basel). 2011; 6(2): 120-125.
Originalarbeiten (Zeitschrift)
Comparison of actual hospital costs versus DRG revenues for in-patient treatment of febrile neutropenia during adjuvant anthracycline plus/minus taxane-based chemotherapy for primary breast cancer.
Jacobs, VR; Mayer, SC; Paessens, BJ; Bernard, R; Harbeck, N; Kiechle, M; Ihbe-Heffinger, A;
Onkologie. 2011; 34(11): 614-618.
Originalarbeiten (Zeitschrift)
Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer.
Knoefel, LF; Werle-Schneider, G; Dally, H; Müller, PJ; Edler, L; Bartsch, H; Tuengerthal, S; Heussel, CP; Reinmuth, N; Thomas, M; Risch, A;
J Thorac Oncol. 2011; 6(1):183-189
Originalarbeiten (Zeitschrift)
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.
Semrau, S; Waldfahrer, F; Lell, M; Linke, R; Klautke, G; Kuwert, T; Uder, M; Iro, H; Fietkau, R;
Strahlenther Onkol. 2011; 187(1): 15-22.
Originalarbeiten (Zeitschrift)
Sentinel Node Biopsy After Primary Chemotherapy in Breast Cancer: A Note of Caution from Results of ABCSG-14
Tausch, C; Steger, GG; Haid, A; Jakesz, R; Fridrik, MA; Reitsamer, R; Postlberger, S; Lang, A; Gnant, M; Greil, R
BREAST J. 2011; 17(3): 230-238.
Originalarbeiten (Zeitschrift)
Perineal reconstruction after rectal and anal disease using the local fascio-cutaneous-infragluteal flap: A new and reliable technique.
Windhofer, C; Michlits, W; Heuberger, A; Papp, C;
SURGERY. 2011; 149(2): 284-290.
Originalarbeiten (Zeitschrift)
Curative treatment of oesophageal carcinoma: current options and future developments.
Wolf, MC; Stahl, M; Krause, BJ; Bonavina, L; Bruns, C; Belka, C; Zehentmayr, F;
Radiat Oncol. 2011; 6: 55
Übersichtsarbeiten
Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer.
Baur, M; Horvath, M; Stättner, S; Schratter-Sehn, A; Horvath, B; Sellner, F; Hudec, M; Klimpfinger, M; Dittrich, C; Karner, J;
Oncol Lett. 2010; 1(1): 18-194.
Originalarbeiten (Zeitschrift)
[Current status of erlotinib and gefitinib in palliative therapy for NSCLC--does the EGF-R mutation state have any significance?].
Brückl, WM; Wiest, GH; Ficker, JH;
Pneumologie. 2010; 64(12): 727-735.
Übersichtsarbeiten
Evidence for the conversion of docetaxel into 7"-epidocetaxel in patients receiving Taxotere-based conventional chemotherapy.
Czejka, M; Greil, R; Ulsperger, E; Schnait, H; Kienesberger, K; Brumnik, T; Farkouh, A; Schierholz, J;
Int J Clin Pharmacol Ther. 2010; 48(7): 483-484.
Abstracts (Zeitschrift)
A stimuli-responsive hydrogel for doxorubicin delivery
Dadsetan, M; Liu, Z; Pumberger, M; Giraldo, CV; Ruesink, T; Lu, LC; Yaszemski, MJ
BIOMATERIALS. 2010; 31(31): 8051-8062.
Originalarbeiten (Zeitschrift)
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin"s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Eich, HT; Diehl, V; Görgen, H; Pabst, T; Markova, J; Debus, J; Ho, A; Dörken, B; Rank, A; Grosu, AL; Wiegel, T; Karstens, JH; Greil, R; Willich, N; Schmidberger, H; Döhner, H; Borchmann, P; Müller-Hermelink, HK; Müller, RP; Engert, A;
J Clin Oncol. 2010; 28(27): 4199-4206.
Originalarbeiten (Zeitschrift)
Reduced treatment intensity in patients with early-stage Hodgkin"s lymphoma.
Engert, A; Plütschow, A; Eich, HT; Lohri, A; Dörken, B; Borchmann, P; Berger, B; Greil, R; Willborn, KC; Wilhelm, M; Debus, J; Eble, MJ; Sökler, M; Ho, A; Rank, A; Ganser, A; Trümper, L; Bokemeyer, C; Kirchner, H; Schubert, J; Král, Z; Fuchs, M; Müller-Hermelink, HK; Müller, RP; Diehl, V;
N Engl J Med. 2010; 363(7): 640-652.
Originalarbeiten (Zeitschrift)
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery.
Fourkala, EO; Hauser-Kronberger, C; Apostolidou, S; Burnell, M; Jones, A; Grall, J; Reitsamer, R; Fiegl, H; Jacobs, I; Menon, U; Widschwendter, M;
BREAST CANCER RES TR. 2010; 120(2): 34-55.
Originalarbeiten (Zeitschrift)
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer.
Gampenrieder, SP; Bartsch, R; Matzneller, P; Pluschnig, U; Dubsky, P; Gnant, MX; Zielinski, CC; Steger, GG;
Breast Care (Basel). 2010; 5(3): 158-162.
Originalarbeiten (Zeitschrift)
Stillbirth in week 19 of pregnancy followed by maternal death as a consequence of refused chemotherapy for non-hodgkin"s lymphoma--significance of adjuvant chemotherapy in women of reproductive age.
Hauenstein, E; Seidl, S; Schneider, KT; Fischer, T;
Onkologie. 2010; 33(12): 692-694.
Originalarbeiten (Zeitschrift)
Dose intensity of chemotherapy in patients with relapsed Hodgkin"s lymphoma.
Josting, A; Müller, H; Borchmann, P; Baars, JW; Metzner, B; Döhner, H; Aurer, I; Smardova, L; Fischer, T; Niederwieser, D; Schäfer-Eckart, K; Schmitz, N; Sureda, A; Glossmann, J; Diehl, V; DeJong, D; Hansmann, ML; Raemaekers, J; Engert, A;
J Clin Oncol. 2010; 28(34): 5074-5080.
Originalarbeiten (Zeitschrift)
Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.
Michlmayr, A; Bachleitner-Hofmann, T; Baumann, S; Marchetti-Deschmann, M; Rech-Weichselbraun, I; Burghuber, C; Pluschnig, U; Bartsch, R; Graf, A; Greil, R; Allmaier, G; Steger, G; Gnant, M; Bergmann, M; Oehler, R;
Br J Cancer. 2010; 103(8): 1201-1208.
Originalarbeiten (Zeitschrift)
Impact of CYP2D6*4 genotype on progression free survival in tamoxifen breast cancer treatment.
Stingl, JC; Parmar, S; Huber-Wechselberger, A; Kainz, A; Renner, W; Seeringer, A; Brockmöller, J; Langsenlehner, U; Krippl, P; Haschke-Becher, E;
Curr Med Res Opin. 2010; 26(11):2535-2542
Originalarbeiten (Zeitschrift)
Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
Wolf, M; Zehentmayr, F; Niyazi, M; Ganswindt, U; Haimerl, W; Schmidt, M; Hölzel, D; Belka, C;
Strahlenther Onkol. 2010; 186(7): 374-381.
Originalarbeiten (Zeitschrift)
Nonresected non-small-cell lung cancer in Stages I through IIIB: accelerated, twice-daily, high-dose radiotherapy--a prospective Phase I/II trial with long-term follow-up.
Wurstbauer, K; Deutschmann, H; Kopp, P; Kranzinger, M; Merz, F; Nairz, O; Studnicka, M; Sedlmayer, F;
INT J RADIAT ONCOL. 2010; 77(5): 134-151.
Originalarbeiten (Zeitschrift)
Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML.
Baumgärtner, AK; Oberhoffer, R; Jacobs, VR; Ostermayer, E; Menzel, H; Voigt, M; Schneider, KT; Pildner von Steinburg, S;
Onkologie. 2009; 32(1-2): 40-43.
Originalarbeiten (Zeitschrift)
Cost analysis comparing an anthracycline/docetaxel regimen to CMF in patients with early stage breast cancer.
Braun, M; Jacobs, VR; Wagenpfeil, S; Sattler, D; Harbeck, N; Nitz, U; Bernard, R; Kuhn, W; Ihbe-Heffinger, A;
Onkologie. 2009; 32(8-9): 473-481.
Originalarbeiten (Zeitschrift)
[Glioblastoma treatment in 2010].
Djedid, R; Tomasi, O; Haidara, A; Rynkowski, M; Lefranc, F;
Rev Med Brux. 2009; 30(5):496-505
Übersichtsarbeiten
Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Gnant, M; Dubsky, P; Fitzal, F; Blaha, P; Schoppmann, S; Steger, G; Marth, C; Samonigg, H; Hüttner, K; Fohler, H; Ruecklinger, E; Jakesz, R; Greil, R;
CLIN BREAST CANCER. 2009; 9 Suppl 1: S18-S27.
Übersichtsarbeiten
Advanced metastatic melanoma during pregnancy: a multidisciplinary challenge.
Gottschalk, N; Jacobs, VR; Hein, R; Fischer, T; Schneider, KT; Pildner von Steinburg, S;
Onkologie. 2009; 32(12): 748-751.
Originalarbeiten (Zeitschrift)
Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study.
Greil, R; Moik, M; Reitsamer, R; Ressler, S; Stoll, M; Namberger, K; Menzel, C; Mlineritsch, B;
EJSO-EUR J SURG ONC. 2009; 35(10): 1048-1054.
Originalarbeiten (Zeitschrift)
PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.
Holler, C; Piñón, JD; Denk, U; Heyder, C; Hofbauer, S; Greil, R; Egle, A;
Blood. 2009; 113(12):2791-2794
Originalarbeiten (Zeitschrift)
Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.
Laimer, M; Namberger, K; Massone, C; Koller, J; Emberger, M; Pleyer, L; Hintner, H; Greil, R;
Acta Derm Venereol. 2009; 89(6): 631-635.
Fallberichte
Is Higher Efficacy Always at the Price of More Side Effects during Chemotherapy?
Mlineritsch, B;
Breast Care (Basel). 2009; 4(3): 162-165.
Originalarbeiten (Zeitschrift)
Consensus of the Austrian Society for Gynecology and Obstetrics/Gynecologic Oncology Working Group Fertility, Contraception and Hormone Replacement Therapy in Oncologic Patients with Special Reference to Breast Cancer
Petru, E; Wildt, L; Stummvoll, W; Singer, C; Speiser, P; Fischerlehner, G; Reitsamer, R; Kubista, E; Marth, C; Winter, R; Menzel, C; Leodolter, S; Seifert, M; Zervomanolakis, I; Zeimet, A; Reinthaller, A
GEBURTSH FRAUENHEILK. 2009; 69(12): 1071-1077.
Originalarbeiten (Zeitschrift)
[Neoadjuvant therapy in the upper gastro-intestinal tract. Modern strategies for Barrett"s cancer].
Stein, HJ; Feith, M; Siewert, JR;
Chirurg. 2009; 80(11):1019-1022
Übersichtsarbeiten
[Transarterial chemoembolization in hepatocellular carcinoma].
Varga, M; Valsamis, A; Matia, I; Peregrin, J; Honsová, E; Safanda, M; Oliverius, M;
Rozhl Chir. 2009; 88(8):434-438
Originalarbeiten (Zeitschrift)
Placental expression of proteases and their inhibitors in patients with HELLP syndrome.
von Steinburg, SP; Krüger, A; Fischer, T; Mario Schneider, KT; Schmitt, M;
Biol Chem. 2009; 390(11): 1199-1204.
Originalarbeiten (Zeitschrift)
Optimized pro-active management of anemia by Epoetin alpha in pre-operative chemotherapy for primary breast cancer.
Warm, M; Kates, R; Dick, M; Thomas, A; Mallmann, P; Hoopmann, M; Harbeck, N;
Oncol Rep. 2009; 21(3):777-785
Originalarbeiten (Zeitschrift)
HX575, recombinant human epoetin alfa, for the treatment of chemotherapy-associated symptomatic anaemia in patients with solid tumours.
Weigang-Köhler, K; Vetter, A; Thyroff-Friesinger, U;
Onkologie. 2009; 32(4): 168-174.
Originalarbeiten (Zeitschrift)
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.
Bartsch, R; Wenzel, C; Gampenrieder, SP; Pluschnig, U; Altorjai, G; Rudas, M; Mader, RM; Dubsky, P; Rottenfusser, A; Gnant, M; Zielinski, CC; Steger, GG;
Cancer Chemother Pharmacol. 2008; 62(5): 903-910.
Originalarbeiten (Zeitschrift)
[Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy].
Brückl, WM; Lampert, S; Zirlik, S; Hahn, EG; Wiest, GH;
Pneumologie. 2008; 62(1):23-30
Übersichtsarbeiten
Increased vascular-endothelial growth factor (VEGF) tumor expression and response to epidermal growth factor receptor (EGF-R) inhibitor erlotinib in non-small cell lung cancer (NSCLC).
Brueckl, WM; Schoeberl, A; Wirtz, RM; Murray, S; Hahn, EG; Wiest, GH;
J Thorac Oncol. 2008; 3(3): 314-316.
Fallberichte
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Dubsky, P; Sevelda, P; Jakesz, R; Hausmaninger, H; Samonigg, H; Seifert, M; Denison, U; Mlineritsch, B; Steger, G; Kwasny, W; Stöger, H; Bartsch, R; Stierer, M; Taucher, S; Fridrik, M; Schippinger, W; Greil, R; Pötter, R; Gnant, M;
Clin Cancer Res. 2008; 14(7):2082-2087
Originalarbeiten (Zeitschrift)
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.
Fischer, H; Taylor, N; Allerstorfer, S; Grusch, M; Sonvilla, G; Holzmann, K; Setinek, U; Elbling, L; Cantonati, H; Grasl-Kraupp, B; Gauglhofer, C; Marian, B; Micksche, M; Berger, W;
MOL CANCER THER. 2008; 7(10): 3408-3419.
Originalarbeiten (Zeitschrift)
Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
Golcher, H; Brunner, T; Grabenbauer, G; Merkel, S; Papadopoulos, T; Hohenberger, W; Meyer, T
EJSO-EUR J SURG ONC. 2008; 34(7): 756-764.
Originalarbeiten (Zeitschrift)
Fibrosarcoma of the childhood mandible.
Gosau, M; Draenert, FG; Winter, WA; Mueller-Hoecker, J; Driemel, O;
Head Face Med. 2008; 4:21
Fallberichte
Cost analysis of febrile neutropenia (FN) management in three tumour types in Germany.
Ihbe-Heffinger, A; Paessens, BJ; von Schilling, C; Ehlken, B; Shlaen, M; Berger, K; Görtz, A; Bernard, R; Peschel, C; Jacobs, VR;
J Clin Oncol. 2008; 26(15_suppl):20651
Originalarbeiten (Zeitschrift)
Incremental costs of chemotherapy-Pharmacoeconomic results from the prospective adjuvant AGO-WSG intergroup EC->DOC trial comparing an anthracycline-docetaxel sequence to CMF in node-positive breast cancer.
Jacobs, VR; Braun, M; Harbeck, N; Wagenpfeil, S; Sattler, D; Bernard, R; Kuhn, W; Ihbe-Heffinger, A;
J Clin Oncol. 2008; 26(15_suppl):583
Originalarbeiten (Zeitschrift)
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
Peintinger, F; Buzdar, AU; Kuerer, HM; Mejia, JA; Hatzis, C; Gonzalez-Angulo, AM; Pusztai, L; Esteva, FJ; Dawood, SS; Green, MC; Hortobagyi, GN; Symmans, WF;
Ann Oncol. 2008; 19(12):2020-2025
Originalarbeiten (Zeitschrift)
Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Peintinger, F; Kuerer, HM; McGuire, SE; Bassett, R; Pusztai, L; Symmans, WF;
Br J Surg. 2008; 95(4):433-437
Originalarbeiten (Zeitschrift)
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
Schmid, P; Kühnhardt, D; Kiewe, P; Lehenbauer-Dehm, S; Schippinger, W; Greil, R; Lange, W; Preiss, J; Niederle, N; Brossart, P; Freier, W; Kümmel, S; Van de Velde, H; Regierer, A; Possinger, K;
Ann Oncol. 2008; 19(5):871-876
Originalarbeiten (Zeitschrift)
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
Taucher, S; Steger, GG; Jakesz, R; Tausch, C; Wette, V; Schippinger, W; Kwasny, W; Reiner, G; Greil, R; Dubsky, P; Poestlberger, S; Tschmelitsch, J; Samonigg, H; Gnant, M;
Breast Cancer Res Treat. 2008; 112(2):309-316
Originalarbeiten (Zeitschrift)
Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group.
Tausch, C; Konstantiniuk, P; Kugler, F; Reitsamer, R; Roka, S; Pöstlberger, S; Haid, A;
Ann Surg Oncol. 2008; 15(12):337-383
Originalarbeiten (Zeitschrift)
Management of venous port systems in oncology: a review of current evidence.
Vescia, S; Baumgärtner, AK; Jacobs, VR; Kiechle-Bahat, M; Rody, A; Loibl, S; Harbeck, N;
Ann Oncol. 2008; 19(1):9-15
Übersichtsarbeiten
Chemotherapy in gastric cancer.
Wöll, E; Devries, A; Eisterer, W; Hejna, M; Keil, F; Stein, H; Zacherl, J; Greil, R;
Anticancer Res. 2008; 28(2B):1213-1219
Übersichtsarbeiten
Biweekly oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. A first-line multicenter phase II trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT).
Wöll, E; Kühr, T; Eisterer, W; Gattringer, K; Greil, R; Zabernigg, A; Hilbe, W; Thaler, J;
Anticancer Res. 2008; 28(5B):2901-2905
Originalarbeiten (Zeitschrift)
Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone).
Zwick, C; Birkmann, J; Peter, N; Bodenstein, H; Fuchs, R; Hänel, M; Reiser, M; Hensel, M; Clemens, M; Zeynalova, S; Ziepert, M; Pfreundschuh, M;
Ann Hematol. 2008; 87(9):717-726
Originalarbeiten (Zeitschrift)
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.
Boeck, S; Weigang-Köhler, K; Fuchs, M; Kettner, E; Quietzsch, D; Trojan, J; Stötzer, O; Zeuzem, S; Lordick, F; Köhne, CH; Kröning, H; Steinmetz, T; Depenbrock, H; Heinemann, V;
Ann Oncol. 2007; 18(4): 74-51.
Originalarbeiten (Zeitschrift)
Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.
Buchholz, S; Schally, AV; Engel, JB; Hohla, F; Heinrich, E; Koester, F; Varga, JL; Halmos, G;
Proc Natl Acad Sci U S A. 2007; 104(6):1943-1946
Originalarbeiten (Zeitschrift)
Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience.
Dawood, S; Gonzalez-Angulo, AM; Peintinger, F; Broglio, K; Symmans, WF; Kau, SW; Islam, R; Hortobagyi, GN; Buzdar, AU;
Cancer. 2007; 110(6): 1195-1200.
Originalarbeiten (Zeitschrift)
The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells.
Gahr, S; Ocker, M; Ganslmayer, M; Zopf, S; Okamoto, K; Hartl, A; Leitner, S; Hahn, EG; Herold, C;
Int J Oncol. 2007; 31(3): 567-576.
Originalarbeiten (Zeitschrift)
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
Mazouni, C; Peintinger, F; Wan-Kau, S; Andre, F; Gonzalez-Angulo, AM; Symmans, WF; Meric-Bernstam, F; Valero, V; Hortobagyi, GN; Pusztai, L;
J Clin Oncol. 2007; 25(19):2650-2655
Originalarbeiten (Zeitschrift)
Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer.
Peintinger, F; Anderson, K; Mazouni, C; Kuerer, HM; Hatzis, C; Lin, F; Hortobagyi, GN; Symmans, WF; Pusztai, L;
Clin Cancer Res. 2007; 13(14):407-482
Originalarbeiten (Zeitschrift)
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
Schippinger, W; Samonigg, H; Schaberl-Moser, R; Greil, R; Thödtmann, R; Tschmelitsch, J; Jagoditsch, M; Steger, GG; Jakesz, R; Herbst, F; Hofbauer, F; Rabl, H; Wohlmuth, P; Gnant, M; Thaler, J;
Br J Cancer. 2007; 97(8):1021-1027
Originalarbeiten (Zeitschrift)
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
Symmans, WF; Peintinger, F; Hatzis, C; Rajan, R; Kuerer, H; Valero, V; Assad, L; Poniecka, A; Hennessy, B; Green, M; Buzdar, AU; Singletary, SE; Hortobagyi, GN; Pusztai, L;
J Clin Oncol. 2007; 25(28):4414-4422
Originalarbeiten (Zeitschrift)
Impact of tumor biological factors on response to pre-operative epirubicin and paclitaxel chemotherapy in primary breast cancer.
Warm, M; Kates, R; Mallmann, P; Dick, M; Nawroth, F; Harbeck, N; Paepke, S; Thomas, A;
Anticancer Res. 2007; 27(2):1031-1038
Originalarbeiten (Zeitschrift)
Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer.
Weiss, C; Engehausen, DG; Krause, FS; Papadopoulos, T; Dunst, J; Saufer, R; Rodel, C
INT J RADIAT ONCOL. 2007; 68(4): 1072-1080.
Originalarbeiten (Zeitschrift)
Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy.
Weiss, C; Rodel, F; Ott, O; Engehausen, DG; Papadopoulos, T; Sauer, R; Rodel, C
STRAHLENTHER ONKOL. 2007; 183(10): 552-556.
Originalarbeiten (Zeitschrift)
Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.
Boughey, JC; Peintinger, F; Meric-Bernstam, F; Perry, AC; Hunt, KK; Babiera, GV; Singletary, SE; Bedrosian, I; Lucci, A; Buzdar, AU; Pusztai, L; Kuerer, HM;
Ann Surg. 2006; 244(3): 464-470.
Originalarbeiten (Zeitschrift)
Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: a retrospective analysis of prospectively recruited patients.
Brunner, TB; Tinkl, D; Grabenbauer, GG; Meyer, T; Brueckl, WM; Sauer, R;
Strahlenther Onkol. 2006; 182(4): 210-215.
Originalarbeiten (Zeitschrift)
Prospective trial on topotecan salvage therapy in primary CNS lymphoma.
Fischer, L; Thiel, E; Klasen, HA; Birkmann, J; Jahnke, K; Martus, P; Korfel, A;
Ann Oncol. 2006; 17(7):1141-1145
Originalarbeiten (Zeitschrift)
G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients.
Krol, J; Paepke, S; Jacobs, VR; Paepke, D; Euler, U; Kiechle, M; Harbeck, N;
Onkologie. 2006; 29(4):171-178
Übersichtsarbeiten
Blood interleukin 12 as preoperative predictor of fatal postoperative sepsis after neoadjuvant radiochemotherapy.
Novotny, AR; Emmanuel, K; Ulm, K; Bartels, H; Siewert, JR; Weighardt, H; Holzmann, B;
Br J Surg. 2006; 93(10):1283-1289
Originalarbeiten (Zeitschrift)
Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Peintinger, F; Kuerer, HM; Anderson, K; Boughey, JC; Meric-Bernstam, F; Singletary, SE; Hunt, KK; Whitman, GJ; Stephens, T; Buzdar, AU; Green, MC; Symmans, WF;
Ann Surg Oncol. 2006; 13(11):1443-1449
Originalarbeiten (Zeitschrift)
The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
Peintinger, F; Symmans, WF; Gonzalez-Angulo, AM; Boughey, JC; Buzdar, AU; Yu, TK; Hunt, KK; Singletary, SE; Babiera, GV; Lucci, A; Meric-Bernstam, F; Kuerer, HM;
Cancer. 2006; 107(6):1248-1254
Originalarbeiten (Zeitschrift)
Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.
Tinhofer, I; Rubenzer, G; Holler, C; Hofstaetter, E; Stoecher, M; Egle, A; Steurer, M; Greil, R;
Blood. 2006; 108(9):2950-2956
Originalarbeiten (Zeitschrift)
Rothia dentocariosa sepsis in a pediatric renal transplant recipient having post-transplant lymphoproliferative disorders.
Wiesmayr, S; Stelzmueller, I; Berger, N; Jungraithmayr, TC; Fille, M; Eller, M; Zimmerhackl, LB; Margreiter, R; Bonatti, H;
Pediatr Transplant. 2006; 10(3):377-379
Fallberichte
Artesunate in the treatment of metastatic uveal melanoma--first experiences.
Berger, TG; Dieckmann, D; Efferth, T; Schultz, ES; Funk, JO; Baur, A; Schuler, G;
Oncol Rep. 2005; 14(6): 1599-1603.
Originalarbeiten (Zeitschrift)
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.
Burger, M; Hartmann, T; Krome, M; Rawluk, J; Tamamura, H; Fujii, N; Kipps, TJ; Burger, JA;
Blood. 2005; 106(5):1824-1830
Originalarbeiten (Zeitschrift)
Long-term results of dose density therapy in patients with aggressive lymphoma.
Fridrik, MA; Hausmaninger, H; Linkesch, W; Greil, R; Krieger, O; Baldinger, C; Klocker, J; Pont, J; Oberaigner, W;
ANN HEMATOL. 2005; 84(4): 217-222.
Originalarbeiten (Zeitschrift)
CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
Hartmann, TN; Burger, JA; Glodek, A; Fujii, N; Burger, M;
Oncogene. 2005; 24(27):4462-4471
Originalarbeiten (Zeitschrift)
An economic model to reduce the cost of chemotherapy for gynecologic cancer.
Jacobs, VR; Thoedtmann, J; Brunner, B; Kiechle, M;
Int J Fertil Womens Med. 2005; 49(6):274-277
Originalarbeiten (Zeitschrift)
Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
Korfel, A; Martus, P; Nowrousian, MR; Hossfeld, DK; Kirchen, H; Brücher, J; Stelljes, M; Birkmann, J; Peschel, C; Pasold, R; Fischer, L; Jahnke, K; Thiel, E;
Br J Haematol. 2005; 128(2):177-183
Originalarbeiten (Zeitschrift)
Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used?
Loehberg, CR; Lux, MP; Ackermann, S; Poehls, UG; Bani, MR; Schulz-Wendtland, R; Papadopoulos, T; Schmucker, M; Beckmann, MW; Fasching, PA
ANTICANCER RES. 2005; 25(3c): 2519-2525.
Originalarbeiten (Zeitschrift)
Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer.
Reitsamer, R; Peintinger, F; Prokop, E; Hitzl, W;
ANTI-CANCER DRUG. 2005; 16(8): 86-70.
Originalarbeiten (Zeitschrift)
B7-h4 is highly expressed in ductal and lobular breast cancer.
Tringler, B; Zhuo, S; Pilkington, G; Torkko, KC; Singh, M; Lucia, MS; Heinz, DE; Papkoff, J; Shroyer, KR;
Clin Cancer Res. 2005; 11(5):1842-1848
Originalarbeiten (Zeitschrift)
Combined-modality treatment and organ preservation in bladder cancer. Do molecular markers predict outcome?
Weiss, C; Rodel, F; Wolf, I; Papadopoulos, T; Engehausen, DG; Schrott, KM; Sauer, R; Rodel, C
STRAHLENTHER ONKOL. 2005; 181(4): 213-222.
Originalarbeiten (Zeitschrift)
The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.
Hartmann, TN; Burger, M; Burger, JA;
J Biol Regul Homeost Agents. 2004; 18(2):126-130
Übersichtsarbeiten
Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr.
Holzner, B; Kemmler, G; Kopp, M; Nguyen-Van-Tam, D; Sperner-Unterweger, B; Greil, R;
Eur J Haematol. 2004; 72(6):381-389
Originalarbeiten (Zeitschrift)
Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons.
Kunzmann, V; Kretzschmar, E; Herrmann, T; Wilhelm, M;
Immunology. 2004; 112(3):369-377
Originalarbeiten (Zeitschrift)
Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
Link, K; Happich, K; Schirner, I; Jüngert, B; Brückl, V; Männlein, G; Brückl, WM; Merkel, S; Göhl, J; Hohenberger, W; Hahn, EG; Wein, A;
Anticancer Res. 2004; 24(1):385-391
Originalarbeiten (Zeitschrift)
Phase II study of single-agent pegylated liposomal doxorubicin HCl (PLD) in metastatic breast cancer after first-line treatment failure.
Mlineritsch, B; Mayer, P; Rass, C; Reiter, E; Russ, G; Vesenmayer, G; Oberaigner, W; Hausmaninger, H;
Onkologie. 2004; 27(5): 441-446.
Originalarbeiten (Zeitschrift)
Treatment of advanced Hodgkinxxxs disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkinxxxs Lymphoma Study Group HD6 trial
Sieber, M; Tesch, H; Pfistner, B; Rueffer, U; Paulus, U; Munker, R; Hermann, R; Doelken, G; Koch, P; Oertel, J; Roller, S; Worst, P; Bischof, H; Glunz, A; Greil, R; von Kalle, K; Schalk, KP; Hasenclever, D; Brosteanu, O; Duehmke, E; Georgii, A; Engert, A; Loeffler, M; Diehl, V
ANN ONCOL. 2004; 15(2): 276-282.
Originalarbeiten (Zeitschrift)
Palliative chemotherapy with gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in metastatic biliary tract and gall bladder adenocarcinomas.
Boxberger, F; Jüngert, B; Brueckl, V; Brueckl, WM; Hautmann, M; Hohenberger, W; Hahn, EG; Wein, A;
Anticancer Drugs. 2003; 14(1):87-90
Fallberichte
Phase II trial with S-1 in chemotherapy-naïve patients with gastric cancer. A trial performed by the EORTC Early Clinical Studies Group (ECSG).
Chollet, P; Schöffski, P; Weigang-Köhler, K; Schellens, JH; Cure, H; Pavlidis, N; Grünwald, V; De Boer, R; Wanders, J; Fumoleau, P;
Eur J Cancer. 2003; 39(9): 1264-1270.
Originalarbeiten (Zeitschrift)
Survival improvement in patients with glioblastoma multiforme during the last 20 years in a single tertiary-care center.
Fazeny-Dörner, B; Gyries, A; Rössler, K; Ungersböck, K; Czech, T; Budinsky, A; Killer, M; Dieckmann, K; Piribauer, M; Baumgartner, G; Prayer, D; Veitl, M; Muhm, M; Marosi, C;
WIEN KLIN WOCHENSCHR. 2003; 115(11): 38-97.
Originalarbeiten (Zeitschrift)
P27 does not predict histopathological response to radiochemotherapy in rectal cancer.
Gunther, K; Dimmler, A; Rodel, F; Reulbach, U; Merkel, S; Bittorf, BR; Matzel, KE; Papadopoulos, T; Hohenberger, W; Sauer, R; Rodel, C
J SURG RES. 2003; 113(2): 179-188.
Originalarbeiten (Zeitschrift)
Nephron-sparing procedures in 11 patients with Wilms" tumor.
Linni, K; Urban, C; Lackner, H; Höllwarth, ME;
Pediatr Surg Int. 2003; 19(6): 457-462.
Originalarbeiten (Zeitschrift)
Catastrophic venous air embolus during prostatectomy in the Trendelenburg position.
Memtsoudis, SG; Malhotra, V;
Can J Anaesth. 2003; 50(10):1084-1085
Letter
A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer.
Paridaens, R; Van Aelst, F; Georgoulias, V; Samonnig, H; Cocquyt, V; Zielinski, C; Hausmaninger, H; Willemse, P; Boudraa, Y; Wildiers, J; Ramazeilles, C; Azli, N;
ANN ONCOL. 2003; 14(3): 433-440.
Originalarbeiten (Zeitschrift)
Feasibility and toxicity of CCNU therapy in elderly patients with glioblastoma multiforme.
Piribauer, M; Fazeny-Dörner, B; Rössler, K; Ungersböck, K; Czech, T; Killer, M; Dieckmann, K; Birner, P; Prayer, D; Hainfellner, J; Muhm, M; Marosi, C;
ANTI-CANCER DRUG. 2003; 14(2): 137-143.
Originalarbeiten (Zeitschrift)
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients.
Ploner, F; Jakesz, R; Hausmaninger, H; Kolb, R; Stierer, M; Fridrik, M; Steindorfer, P; Gnant, M; Haider, K; Mlineritsch, B; Tschurtschenthaler, G; Steger, G; Seifert, M; Kubista, E; Samonigg, H;
Onkologie. 2003; 26(2):115-119
Originalarbeiten (Zeitschrift)
What is CD4+CD56+malignancy and how should it be treated?
Reimer, P; Rudiger, T; Kraemer, D; Kunzmann, V; Weissinger, F; Zettl, A; Muller-Hermelink, HK; Wilhelm, M
BONE MARROW TRANSPL. 2003; 32(7): 637-646.
Übersichtsarbeiten
Subcutaneous panniculitis-like T-cell lymphoma during pregnancy with successful autologous stem cell transplantation
Reimer, P; Rudiger, T; Muller, J; Rose, C; Wilhelm, M; Weissinger, F
ANN HEMATOL. 2003; 82(5): 305-309.
Originalarbeiten (Zeitschrift)
Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer, R; Peintinger, F; Rettenbacher, L; Prokop, E;
J Surg Oncol. 2003; 84(2):63-67
Originalarbeiten (Zeitschrift)
Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatin.
Stickel, F; Jüngert, B; Brueckl, V; Schirner, I; Brueckl, WM; Männlein, G; Hegewald, J; Mühldorfer, S; Bittorf, B; Hohenberger, W; Hahn, EG; Wein, A;
Anticancer Drugs. 2003; 14(9):745-749
Originalarbeiten (Zeitschrift)
[Palliative second-line treatment with oxaliplatin, gemcitabine and weekly high-dose 5-fluorouracil as 24-h infusion in patients with metastatic pancreatic adenocarcinoma].
Boxberger, F; Happich, K; Schirner, I; Brueckl, WM; Hohenberger, W; Hahn, EG; Wein, A;
Z Gastroenterol. 2002; 40(10):881-884
Fallberichte
Diffuse large B-cell lymphoma with infiltration-associated peripheral neuropathy and paraneoplastic myopathy with a prolonged course over seven years.
Fiegl, M; Muigg, A; Smekal, A; Krugmannd, J; Dirnhofer, S; Greil, R;
Leuk Lymphoma. 2002; 43(8): 1687-1690.
Originalarbeiten (Zeitschrift)
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Hänel, M; Kröger, N; Sonnenberg, S; Bornhäuser, M; Krüger, W; Kroschinsky, F; Hänel, A; Metzner, B; Birkmann, J; Schmid, B; Hoffknecht, MM; Fiedler, F; Ehninger, G; Zander, AR;
Ann Hematol. 2002; 81(2): 96-102.
Originalarbeiten (Zeitschrift)
The impact of hemoglobin levels on fatigue and quality of life in cancer patients.
Holzner, B; Kemmler, G; Greil, R; Kopp, M; Zeimet, A; Raderer, M; Hejna, M; Zöchbauer, S; Krajnik, G; Huber, H; Fleischhacker, WW; Sperner-Unterweger, B;
Ann Oncol. 2002; 13(6): 965-973.
Originalarbeiten (Zeitschrift)
Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
Jäger, G; Neumeister, P; Brezinschek, R; Hinterleitner, T; Fiebiger, W; Penz, M; Neumann, HJ; Mlineritsch, B; DeSantis, M; Quehenberger, F; Chott, A; Beham-Schmid, C; Höfler, G; Linkesch, W; Raderer, M;
J Clin Oncol. 2002; 20(18): 3872-3877.
Originalarbeiten (Zeitschrift)
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
Jakesz, R; Hausmaninger, H; Kubista, E; Gnant, M; Menzel, C; Bauernhofer, T; Seifert, M; Haider, K; Mlineritsch, B; Steindorfer, P; Kwasny, W; Fridrik, M; Steger, G; Wette, V; Samonigg, H;
J Clin Oncol. 2002; 20(24):4621-4627
Originalarbeiten (Zeitschrift)
Chemotherapy versus hormonal adjuvant treatment in premenopausal patients with breast cancer.
Jakesz, R; Hausmaninger, H; Samonigg, H;
Eur J Cancer. 2002; 38(3): 327-332.
Übersichtsarbeiten
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
Kaiser, U; Uebelacker, I; Abel, U; Birkmann, J; Trümper, L; Schmalenberg, H; Karakas, T; Metzner, B; Hossfeld, DK; Bischoff, HG; Franke, A; Reiser, M; Müller, P; Mantovani, L; Grundeis, M; Rothmann, F; von Seydewitz, CU; Mesters, RM; Steinhauer, EU; Krahl, D; Schumacher, K; Kneba, M; Baudis, M; Schmitz, N; Pfab, R; Köppler, H; Parwaresch, R; Pfreundschuh, M; Havemann, K;
J Clin Oncol. 2002; 20(22): 4413-4419.
Originalarbeiten (Zeitschrift)
Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer.
Rodel, C; Grabenbauer, GG; Papadopoulos, T; Bigalke, M; Gunther, K; Schick, C; Peters, A; Sauer, R; Rodel, F
INT J RADIAT ONCOL. 2002; 52(2): 294-303.
Originalarbeiten (Zeitschrift)
High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection.
Rodel, F; Hoffmann, J; Grabenbauer, GG; Papadopoulos, T; Weiss, C; Gunther, K; Schick, C; Sauer, R; Rodel, C
STRAHLENTHER ONKOL. 2002; 178(8): 426-435.
Originalarbeiten (Zeitschrift)
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin"s lymphoma: final results of the German Hodgkin"s Lymphoma Study Group Trial HD5.
Sieber, M; Tesch, H; Pfistner, B; Rueffer, U; Lathan, B; Brosteanu, O; Paulus, U; Koch, T; Pfreundschuh, M; Loeffler, M; Engert, A; Josting, A; Wolf, J; Hasenclever, D; Franklin, J; Duehmke, E; Georgii, A; Schalk, KP; Kirchner, H; Doelken, G; Munker, R; Koch, P; Herrmann, R; Greil, R; Anselmo, AP; Diehl, V;
J Clin Oncol. 2002; 20(2): 476-484.
Originalarbeiten (Zeitschrift)
Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin"s disease: long-term results of a randomized trial of radiotherapy alone.
Dühmke, E; Franklin, J; Pfreundschuh, M; Sehlen, S; Willich, N; Rühl, U; Müller, RP; Lukas, P; Atzinger, A; Paulus, U; Lathan, B; Rüffer, U; Sieber, M; Wolf, J; Engert, A; Georgii, A; Staar, S; Herrmann, R; Beykirch, M; Kirchner, H; Emminger, A; Greil, R; Fritsch, E; Koch, P; Drochtert, A; Brosteanu, O; Hasenclever, D; Loeffler, M; Diehl, V;
J Clin Oncol. 2001; 19(11): 2905-2914.
Originalarbeiten (Zeitschrift)
Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.
Hänel, M; Kröger, N; Kroschinsky, F; Birkmann, J; Hänel, A; Herbst, R; Naumann, R; Friedrichsen, K; Ehninger, G; Zander, AR; Fiedler, F;
J Cancer Res Clin Oncol. 2001; 127(6):387-395
Originalarbeiten (Zeitschrift)
Disseminated manifestation of Kaposi"s Sarcoma in newly diagnosed AIDS in an african female.
Harsch, IA; Kraetsch, HG; Amann, K; Hahn, EG; Ficker, JH; Konturek, PC;
Med Sci Monit. 2001; 7(6): 1303-1306.
Fallberichte
Antimicrobial resistance in pasteurella and mannheimia: epidemiology and genetic basis.
Kehrenberg, C; Schulze-Tanzil, G; Martel, JL; Chaslus-Dancla, E; Schwarz, S;
Vet Res. 2001; 32(3-4): 32-39.
Übersichtsarbeiten
Prognostic influence of delays between exploratory and definitive laparotomy in the treatment of malignant ovarian tumors.
Lehner, R; Szabo, S; Goharkhy, N; Jirecek, S; Tringler, B; Sevelda, P;
Arch Gynecol Obstet. 2001; 265(1): 36-39.
Originalarbeiten (Zeitschrift)
Weekly 24-h infusion of high-dose 5-fluorouracil (5-FU) with folinic acid (FA) in adjuvant therapy of colon cancer.
Wein, A; Riedel, C; Brückl, W; Kastl, S; Reingruber, B; Hohenberger, W; Hahn, EG;
Z Gastroenterol. 2001; 39(2): 153-156.
Originalarbeiten (Zeitschrift)
Non-small-cell lung cancer: dose escalation by target splitting with asymmetric collimation.
Wurstbauer, K; Deutschmann, H; Sedlmayer, F; Kogelnik, HD;
Clin Lung Cancer. 2001; 3(2): 151-153.
Originalarbeiten (Zeitschrift)
Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments.
Behr, TM; Blumenthal, RD; Memtsoudis, S; Sharkey, RM; Gratz, S; Becker, W; Goldenberg, DM;
Clin Cancer Res. 2000; 6(12):4900-4907
Originalarbeiten (Zeitschrift)
A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma.
Halm, U; Etzrodt, G; Schiefke, I; Schmidt, F; Witzigmann, H; Mössner, J; Berr, F;
Ann Oncol. 2000; 11(1): 113-114.
Originalarbeiten (Zeitschrift)
Laposcopic retroperitoneal lymph node dissection: evolution of a new technique.
Janetschek, G;
World J Urol. 2000; 18(4): 26-71.
Übersichtsarbeiten
Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer.
Krajnik, G; Mohn-Staudner, A; Thaler, J; Greil, R; Schmeikal, S; Marhold, F; Deutsch, J; Preiss, P; Malayeri, R; Schäfer-Prokop, C; Wein, W; Huber, H; Pirker, R;
Ann Oncol. 2000; 11(8): 993-998.
Originalarbeiten (Zeitschrift)
Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI.
Lell, M; Baum, U; Greess, H; Nömayr, A; Nkenke, E; Koester, M; Lenz, M; Bautz, W;
Eur J Radiol. 2000; 33(3):239-247
Originalarbeiten (Zeitschrift)
Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation.
Rodel, C; Grabenbauer, GG; Rodel, F; Birkenhake, S; Kuhn, R; Martus, P; Zorcher, T; Fursich, D; Papadopoulos, T; Dunst, J; Schrott, KM; Sauer, R
INT J RADIAT ONCOL. 2000; 46(5): 1213-1221.
Originalarbeiten (Zeitschrift)
Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer.
Rodel, C; Grabenbauer, GG; Schick, C; Papadopoulos, T; Hohenberger, W; Sauer, R
STRAHLENTHER ONKOL. 2000; 176(4): 161-167.
Originalarbeiten (Zeitschrift)
Management of renal complications in patients with advanced multiple myeloma.
Viertel, A; Weidmann, E; Ditting, T; Geiger, H;
Leuk Lymphoma. 2000; 38(5-6):513-519
Originalarbeiten (Zeitschrift)
Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature
Al-Taie, OH; Mork, H; Gassel, AM; Wilhelm, M; Weissbrich, B; Scheurlen, M
ANN HEMATOL. 1999; 78(5): 247-249.
Fallberichte
The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complications.
Goerner, M; Wandt, H; Schäfer-Eckart, K; Birkmann, J; Denzel, T; Gallmeier, WM;
J Hematother Stem Cell Res. 1999; 8(4): 387-391.
Originalarbeiten (Zeitschrift)
Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin"s disease from 1969 to 1994.
Greil, R; Holzner, B; Kemmler, G; Kopp, M; Buchowski, A; Oberaigner, W; Fritsch, E; Dirnhofer, S; Rueffer, U; Diehl, V; Sperner-Unterweger, B;
Eur J Cancer. 1999; 35(5): 698-706.
Originalarbeiten (Zeitschrift)
Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-alpha-2c in patients with advanced colorectal cancer: final results of a randomised phase III study.
Hausmaninger, H; Moser, R; Samonigg, H; Mlineritsch, B; Schmidt, H; Pecherstorfer, M; Fridrik, M; Kopf, C; Nitsche, D; Kaider, A; Ludwig, H;
Eur J Cancer. 1999; 35(3): 380-385.
Originalarbeiten (Zeitschrift)
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer.
Jakesz, R; Hausmaninger, H; Haider, K; Kubista, E; Samonigg, H; Gnant, M; Manfreda, D; Tschurtschenthaler, G; Kolb, R; Stierer, M; Fridrik, M; Mlineritsch, B; Steindorfer, P; Mittlböck, M; Steger, G;
J Clin Oncol. 1999; 17(6): 1701-1709.
Originalarbeiten (Zeitschrift)
Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma.
Janetschek, G; Hobisch, A; Hittmair, A; Höltl, L; Peschel, R; Bartsch, G;
J Urol. 1999; 161(2): 477-481.
Originalarbeiten (Zeitschrift)
Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer.
Wandt, H; Birkmann, J; Denzel, T; Schäfer, K; Schwab, G; Pilz, D; Egger, H; Both, A; Gallmeier, WM;
Bone Marrow Transplant. 1999; 23(8): 763-770.
Originalarbeiten (Zeitschrift)
Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin"s lymphoma.
Fridrik, MA; Jäger, G; Kienzer, HR; Hausmaninger, H; Oppitz, P; Krieger, O; Zabernigg, A; Lang, A; Neubauer, M; Weidinger, G; Schiller, L; Seewann, HL; Chott, A; Linkesch, W;
Eur J Cancer. 1998; 34(10): 1560-1564.
Originalarbeiten (Zeitschrift)
Prognosis and management strategies of lymphatic neoplasias in the elderly. I. Aggressive non-Hodgkin"s lymphomas.
Greil, R;
Oncology. 1998; 55(3): 189-217.
Übersichtsarbeiten
Prognosis and management strategies of lymphatic neoplasias in the elderly. II. Hodgkin"s disease.
Greil, R;
Oncology. 1998; 55(4): 265-275.
Übersichtsarbeiten
[Therapy studies of the Austrian Breast Cancer Group (ABC)].
Jakesz, R; Hausmaninger, H; Samonigg, H; Kubista, E; Haider, K; Mlineritsch, B; Schmid, M; Tausch, C; Reiner, G; Renner, K; Stierer, M; Jatzko, G; Hofbauer, F; Fridrik, M; Schennach, W; Sevelda, P; Dadak, C; Haid, A; Scholz, R; Lenzhofer, P; Steindorfer, P; Berger, A; Mischinger, HJ;
Zentralbl Chir. 1998; 123 Suppl 5: 28-32.
Originalarbeiten (Zeitschrift)
Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trial.
Krajnik, G; Wein, W; Greil, R; Marhold, F; Mohn-Staudner, A; Kummer, F; Malayeri, R; Zöchbauer-Müller, S; Huber, H; Pirker, R;
Eur J Cancer. 1998; 34(12): 1977-1980.
Originalarbeiten (Zeitschrift)
A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma.
Engert, A; Schnell, R; Küpper, F; Reiser, M; Engelhard, M; Wilhelm, M; Lathan, B; Baltes-Engler, S; Winterhalter, B; Scheulen, ME; Dederichs, B; Tesch, H; Wörmann, B; Diehl, V;
Leuk Lymphoma. 1997; 24(5-6): 513-522.
Originalarbeiten (Zeitschrift)
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin"s lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor Therapy.
Fridrik, MA; Greil, R; Hausmaninger, H; Krieger, O; Oppitz, P; Stöger, M; Klocker, J; Neubauer, M; Helm, W; Pont, J; Fazeny, B; Hudec, M; Simonitsch, I; Radaszkiewicz, T;
Ann Hematol. 1997; 75(4):135-140
Originalarbeiten (Zeitschrift)
Adjunctive interferon-alpha-2c in stage IIIB/IV small-cell lung cancer: a phase III trial.
Prior, C; Oroszy, S; Oberaigner, W; Schenk, E; Kummer, F; Aigner, K; Hausmaninger, H; Peschel, C; Huber, H;
Eur Respir J. 1997; 10(2): 392-396.
Originalarbeiten (Zeitschrift)
[High dose chemotherapy with autologous stem cell transplantation].
Weissinger, F; Reimer, P; Wilhelm, M;
Fortschr Med. 1997; 115(9): 39-43.
Übersichtsarbeiten
2",2"-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA).
Gruber, J; Geisen, F; Sgonc, R; Egle, A; Villunger, A; Boeck, G; Konwalinka, G; Greil, R;
Stem Cells. 1996; 14(3):351-362
Originalarbeiten (Zeitschrift)
LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells.
Oez, S; Trautmann, U; Smetak, M; Birkmann, J; al salemeh, S; Gebhart, E; Gallmeier, WM;
Ann Hematol. 1996; 72(5): 307-316.
Originalarbeiten (Zeitschrift)
Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer.
Sagaster, P; Flamm, J; Flamm, M; Mayer, A; Donner, G; Oberleitner, S; Havelec, L; Lepsinger, L; Ludwig, H;
Eur J Cancer. 1996; 32A(8):1320-1324
Originalarbeiten (Zeitschrift)
The influence of lymph- and haemangiosis carcinomatosa in colorectal cancer
Schultheis, KH; Kosicki, C; Ruckriegel, S; Meyer, W; Gebhardt, C; Kaiser, A; Wunsch, P
ZBL CHIR. 1996; 121(6): 442-449.
Originalarbeiten (Zeitschrift)
Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin"s lymphoma.
Hopfinger, G; Heinz, R; Koller, E; Schneider, B; Pittermann, E;
Eur J Haematol. 1995; 55(4): 223-227.
Originalarbeiten (Zeitschrift)
Will neoadjuvant chemotherapy affect the capacity of head and neck squamous cell carcinoma to bind neoglycoproteins?
Steuer, MK; Steuer, M; Bonkowsky, V; Strutz, J; Gabius, HJ; Hofstädter, F;
ORL J Otorhinolaryngol Relat Spec. 1995; 57(1): 22-27.
Originalarbeiten (Zeitschrift)
Response of untreated stage IV Wilms" tumor to single dose carboplatin assessed by "up front" window therapy.
Zoubek, A; Kajtar, P; Flucher-Wolfram, B; Holzinger, B; Mostbeck, G; Thun-Hohenstein, L; Fink, FM; Urban, C; Mutz, I; Schuler, D;
Med Pediatr Oncol. 1995; 25(1): 8-11.
Originalarbeiten (Zeitschrift)
[Hepatocellular carcinoma in pregnancy].
Brucker, C; Weiss, M; Schweiberer, L; Genz, T; Maassen, V; Debus-Thiede, G;
Geburtshilfe Frauenheilkd. 1994; 54(5):305-307
Fallberichte
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin"s lymphomas: treatment results and prognostic factor analysis in a multi-centre trial.
Köppler, H; Pflüger, KH; Eschenbach, I; Pfab, R; Birkmann, J; Zeller, W; Holle, R; Steinhauer, UE; Gropp, C; Oehl, S;
Ann Oncol. 1994; 5(1): 49-55.
Originalarbeiten (Zeitschrift)
[Current status of therapy of CNS metastases of germ cell tumors].
Clemm, C; Gerl, A; Wendt, TG; Pöllinger, B; Winkler, PA; Wilmanns, W;
Urologe A. 1993; 32(3): 217-224.
Originalarbeiten (Zeitschrift)
[Antibacterial chemotherapy of "septic kidney"].
Janetschek, G; Girstmair, J; Semenitz, E; Dierich, MP;
Wien Klin Wochenschr. 1993; 105(3): 84-88.
Originalarbeiten (Zeitschrift)
Growth after radiotherapy and chemotherapy in children with leukemia or lymphoma.
Thun-Hohenstein, L; Frisch, H; Schuster, E;
Horm Res. 1992; 37(3): 91-95.
Originalarbeiten (Zeitschrift)
Toxicity and preliminary results with a new eight-drug regimen (CEOP-IMVP-DEXA) in the treatment of aggressive lymphomas.
Fridrik, MA; Hausmaninger, H; Michlmayr, G; Haidinger, R; Seewann, HL; Lehnert, M;
Hematol Oncol. 1991; 9(4-5): 209-215.
Originalarbeiten (Zeitschrift)
Sequential versus alternating chemotherapy for high grade non-Hodgkin"s lymphomas: a randomized multicentre trial.
Köppler, H; Pflüger, KH; Eschenbach, I; Pfab, R; Birkmann, J; Zeller, W; Steinhauer, EU; Gropp, C; Oehl, S; Lötzke, E;
Hematol Oncol. 1991; 9(4-5): 217-223.
Originalarbeiten (Zeitschrift)
Combined percutaneous and transurethral approach to stenoses of the ureteral meatus after transurethral resection for bladder tumor.
Janetschek, G; Eberle, J; Jakse, G;
Eur Urol. 1989; 16(1): 31-35.
Originalarbeiten (Zeitschrift)
Leukemic samples characteristics associated with clonogenic growth.
Birkmann, J; Früh, U; Hofmann, V;
Leuk Res. 1986; 10(1): 59-63.
Originalarbeiten (Zeitschrift)